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Abstract 
 
The emergence of counterfeit and substandard medicines is a worldwide problem that has 
been growing over the years. The use of these medicines puts people’s health at risk, which can 
even result in death. It is estimated that 5% of the antibiotics on the market are counterfeit and 
that most of these are -lactams. Despite being a worldwide problem, its incidence is higher in 
less developed countries due to limited access to quality medical products at an affordable price 
and the lack of sophisticated means for their detection. Most of the techniques used to validate 
the purity of an antibiotic require specialized technicians, adequate infrastructures and expensive 
equipment, which makes it impossible to use in resource-poor countries. 
The main goal of this dissertation is to develop an inexpensive and user-friendly device, 
able to detect counterfeit -lactam antibiotics. This detection is based on checking for the pres-
ence of the active pharmaceutical ingredient (API) in the antibiotic and verifying if it is within 
the correct dosage. The device consists of a paper-based platform, obtained by Lab-on-Paper 
technology, with an enzyme-free detection, based on the use of gold nanoparticles. In the presence 
of the API, the HAuCl4 is reduced and gold nanoparticles (GNPs) are formed, allowing a colori-
metric detection. This reaction was tested with solutions of different volumes and concentrations 
of antibiotic and calibration curves were obtained, from digital analysis, to obtain the dosage of 
that antibiotic. Solutions of common drug replacements were used to verify if there is formation 
of GNPs without the API.  
Keywords: counterfeit -lactam antibiotics, enzyme-free platform, gold nanoparticles, paper-
based sensor 
xi 
Resumo 
 
O aparecimento de medicamentos falsificados e de baixa qualidade é um problema mun-
dial que tem vindo a intensificar-se ao longo dos anos. O uso destes medicamentos coloca a saúde 
das pessoas em risco, podendo resultar em morte. É estimado que 5% dos antibióticos no mercado 
são falsificados e que a maioria desses antibióticos são -lactâmicos. Apesar de ser um problema 
mundial, a sua incidência é maior em países em desenvolvimento devido ao acesso limitado a 
produtos médicos de qualidade a preço acessível e à falta de meios sofisticados para a sua deteção. 
A maioria das técnicas utilizadas para validar a pureza de um antibiótico, requerem técnicos es-
pecializados, infraestruturas adequadas e equipamentos caros, o que impossibilita o seu uso em 
países com poucos recursos.  
O objetivo desta dissertação é desenvolver um dispositivo barato e de fácil utilização para 
a deteção de antibióticos -lactâmicos falsificados. Essa deteção é baseada na confirmação da 
presença do princípio farmacêutico ativo (API) no antibiótico e na identificação da sua dose. O 
sensor em papel é obtido através da tecnologia Lab-on-Paper e utiliza nanopartículas de ouro 
(GNPs) com meio de deteção. Na presença do API o HAuCl4 é reduzido e são formadas GNPs, 
permitindo uma deteção colorimétrica e não enzimática. Esta reação foi testada com diferentes 
volumes e concentrações de antibiótico e foram obtidas curvas de calibração, a partir da análise 
digital, para obter a dose desse antibiótico. Foram utilizadas soluções de substitutos de medica-
mentos para verificar se há formação de GNPs na ausência do API. 
Palavras-chave: antibióticos -lactâmicos falsificados, sensor não enzimático, nanopartículas de 
ouro, sensor em papel 
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1 Introduction and Objectives 
 According to the World Health Organization (WHO), counterfeit/falsified and substand-
ard medical products have been increasing over the years. These products are considered medical 
products with a fraudulent presentation of identity, composition and origin or medical products 
that do not meet quality standards, respectively. Substandard medical products may be poorly 
manufactured, poorly packed or poorly transported. Falsified medical products may contain the 
correct Active Pharmaceutical Ingredient (API) in different concentrations than expected, not 
contain the correct API or contain the wrong compounds [1]. An API is a substance used in the 
manufacture of a medical product, which exerts a pharmacological, immunological or metabolic 
action to restore and correct physiological functions or establish a medical diagnosis. Any other 
substance in a medical product is referred to as an excipient [2]. 
 The use of counterfeit and substandard medical products puts people’s health in danger 
and leads to failures in the treatment of illness, which may even result in death. These failures 
result in a loss of confidence in the drugs and the health system and contribute to the expansion 
of drug resistance. Antibiotics and other antimicrobials are manufactured in such a way as to 
contain doses capable of destroying the pathogens present in the body. If they contain only a 
fraction of the correct dose or are poorly manufactured, only a few of these pathogens will be 
destroyed. Survivors are the pathogens that acquire mutations that allow them to survive low 
doses of medication. This could lead to the development of drug resistant infections which, due 
to the evolution of the means of transport, could easily be transmitted to other countries [1]. 
 Between 2013 and 2017, 1500 counterfeit and substandard medical products were re-
ported in various regions of the world (Figure 1.1) [1]. It is estimated that 5% of the antibiotics 
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present on the world market are counterfeit and that within these, beta-lactam (-lactam) antibi-
otics are the most common [3]. Studies have shown that the most counterfeit -lactam antibiotics 
of the penicillin and cephalosporin classes are amoxicillin, ampicillins and ceftazidime [4]. Alt-
hough this problem is worldwide, its incidence is higher in countries where: 
• Access to affordable and safe quality medical products is limited; 
• There are gaps in governance, poor ethical practices in health care and corruption in the 
private and public sectors; 
• Equipment and technical capacity to ensure good manufacturing practices, quality con-
trol, storage and distribution are limited [1].  
 
Figure 1.1 Detection of counterfeit and substandard products worldwide 
The countries in which counterfeit and substandard medical products have been discovered and reported 
to WHO between 2013 and 2017 are represented in blue. Adapted from [1] 
 The standard procedure for determining the purity of a drug is based on mass spectrom-
etry and high-performance liquid chromatography (HPLC). This requires specialized technicians, 
adequate infrastructures and expensive equipment, which makes it difficult to carry out these 
procedures in less developed countries [3]. Consequently, in conditions of few resources the as-
sessment of the purity of the medicines is hampered. The means available for this purpose are 
less precise and have the disadvantage of requiring chemicals, standard samples, trained people 
to perform them, a high initial investment or a limited lifetime. 
 The purpose of this thesis is to develop an inexpensive and user-friendly device, able to 
distinguish legitimate from counterfeit antibiotics. As most of the worldwide counterfeit antibi-
otics are -lactams, antibiotics from this group will be used, namely penicillins and cephalospor-
ins. This device shall consist of a non-enzymatic, microfluidic paper device with a colorimetric 
3 
detection obtained through metal nanoparticles. The use of paper as diagnostic support makes the 
sensor inexpensive, equipment free and easy to use. The evaluation of the colour can be done 
using a smartphone which removes the need for specialized technicians. Another advantage of 
this device is the absence of enzymes, which increases the shelf life of the sensor and its resistance 
to transport and storage conditions. The main goals of this project are: 
i. Synthesis of gold nanoparticles (GNPs) in solution by reduction of HAuCl4 by the anti-
biotics’ amine group; 
ii. Application of the previous synthesis on paper substrate and establishment of protocols 
for each antibiotic; 
iii. Testing the previous protocols with common drug replacements; 
iv. Proof of concept development of a non-enzymatic paper-based device to distinguish le-
gitimate from counterfeit antibiotics. 
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2 Concepts 
 In this chapter, the theoretical foundations necessary for a better understanding of this 
thesis are presented. Within the theory associated with this project, it is important to understand 
the function of paper-based microfluidics and colorimetric detection using gold nanoparticles. In 
addition, it is essential to understand the concept of sensor and antibiotic. 
2.1 Antibiotics 
Antibiotics are substances of biological or synthetic origin, capable of killing or inhibiting 
the growth of bacteria [5]. Most antibiotics result from the purification and chemical modification 
of colonies of microorganisms, which qualifies them as semi-synthetic antibiotics [6]. Antibiotics 
can be classified according to their in vitro behaviour, their molecular structure or according to 
their mode of action. According to classification based on in vitro behaviour, antibiotics may be 
designated as bactericidal or bacteriostatic. Bactericides kill bacteria while bacteriostats inhibit 
their growth. Classification according to molecular structure considers the molecular geometry 
and electronic structure of the antibiotic. The mode of action includes inhibition of cell wall syn-
thesis, alteration of cell membrane structure or function, inhibition of nucleic acid function and 
structure, inhibition of protein synthesis at ribosomes, and blocking of metabolism [5].  
2.2 Penicillins 
 The first antibiotic discovered was the penicillin, in 1928, by Alexander Fleming [5]. This 
antibiotic is derived from the fungus Penicillium chrysogenum and is part of the -lactam antibi-
otic group. Its chemical structure has a -lactam ring, a thiazolidine ring and a side chain (Figure 
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2.1). The -lactam ring and the thiazolidine ring form the nucleus of the penicillins, called 6-
aminopenicillanic acid (6-APA). The stability of the antibiotic and its activity against different 
bacteria is determined according to the variable side chain group (R). Altering this group allows 
different types of penicillin to be obtained (Figure 2.2) [7].  
 
Figure 2.1 General structure of penicillins 
R: side chain variable group; A: -lactam ring; B: thiazolidine ring. Adapted from [5] 
 
 
Figure 2.2 Benzylpenicillin, amoxicillin and ampicillin structure 
The alteration of the side chain variable group allows obtaining different types of penicillin [8]. 
 Penicillins act as bactericidal agents, because inhibits the bacterial cell wall synthesis and 
has been used to treat bacterial infections, such as ear infections, bladder infections, gonorrhoea, 
Escherichia coli or Salmonella infections, upper respiratory tract infections, pneumonia, skin and 
soft tissue infections, septicaemia, meningitis, endocarditis and gastrointestinal tract infections 
[7]. These antibiotics can be divided into natural penicillins and semi-synthetic penicillins. Natu-
ral penicillins result from fermentation processes of the fungus Penicillium and are part of this 
group benzylpenicillin (penicillin G) and phenoxymethylpenicillin (penicillin V). These penicil-
lins present some drawbacks, such as their narrow spectrum of activity and their susceptibility to 
inactivation by -lactamases and penicillinase. -lactamase are enzymes produced by bacteria 
which break down the -lactam ring. Penicillin-specific -lactamases are called penicillinase.  
 Semi-synthetic penicillins have been developed to overcome the disadvantages of natural 
penicillins and result from the chemical addition of side chains to the 6-APA produced by the 
fungus. 6-APA is obtained by disrupting the synthesis of the penicillin molecule to obtain only 
the common nucleus, or by removing the side chains. The semi-synthetic penicillins are divided 
into penicillinase-resistant penicillins, extended spectrum penicillins and -lactamase inhibiting 
penicillins. The penicillinase-resistant penicillins are not activated by the penicillinase enzyme 
and examples of these penicillins are methicillin, oxacillin, cloxacillin, dicloxacillin and nafcillin. 
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The extended spectrum penicillins have the widest antibacterial spectrum and are subdivided into 
aminopenicillins (amoxicillin and ampicillin), carboxypenicillins (carbenicillin and ticarcillin) 
and ureidopenicillins (mezlocillin and azlocillin). -lactamase inhibiting penicillins result from 
the combination of penicillins with -lactamase inhibitors and are used in treatments for infec-
tions caused by -lactamase producing bacteria. Amoxicillin-clavulanate and ticarcillin-clavula-
nate are examples of penicillins of this group [7], [9]. 
2.3 Cephalosporins 
 Cephalosporins are the most used -lactam antibiotics and have a similar structure and 
mode of action to penicillins (Figure 2.3). Its chemical structure consists of a -lactam ring, a 
dihydrothiazine ring and a side chain (Figure 2.4). The -lactam ring and the dihydrothiazine 
ring form the nucleus of cephalosporins, called 7-aminocephalosporanic acid (7-ACA). The al-
teration of the variable groups allows to obtain different types of cephalosporins (Figure 2.5) [5], 
[10]. 
 
Figure 2.3 Cephalosporin and penicillin nuclear structures 
A: Cephalosporin; B: Penicillin. Adapted from [11] 
 
Figure 2.4 General structure of cephalosporins 
R: side chain variable groups 1 and 2; A: -lactam ring; B: dihydrothiazine ring. Adapted from [5] 
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 The first cephalosporin antibiotic was isolated in 1945 from the fungus Cephalosporium 
acremonium. These antibiotics also act as bactericidal agents, disrupting the synthesis of the bac-
terial cell wall and turning the bacteria susceptible to the environment [12]. Cephalosporins are 
used to treat skin or soft tissue infections, urinary tract infections, ear infections, pneumonia, 
gonorrhoea, bronchitis, bone and joint infections [13]. These antibiotics are subdivided into five 
generations according to their target organism [5]. First-generation cephalosporins have a rela-
tively restricted action spectrum, specifically against gram-positive bacteria, while the successive 
generations are increasingly more effective against gram-negative bacteria and have a more ex-
tended spectrum [5]. Cefaclor and cefuroxime are examples of cephalosporins of second genera-
tion and ceftazidime is an example of a cephalosporin of third generation.  
 
Figure 2.5 Cefaclor, cefuroxime and ceftazidime structure 
The alteration of the variable groups allows to obtain different types of cephalosporins [8] 
 In this thesis, -lactam antibiotics from the two different groups previously mentioned 
were used: amoxicillin and ampicillin from the penicillin group and ceftazidime from the cepha-
losporin group.  
2.4 Sensors 
A sensor is an element of a measuring system that is directly affected by a phenomenon, 
body, or substance carrying a quantity to be measured. The presence of the phenomenon, body, 
or substance can be indicated by a detector when a threshold value of an associated quantity is 
exceeded [14]. A sensor can be characterized by the following parameters:  
• Sensitivity: quotient of the change in an indication of a measuring system and the 
corresponding change in a value of a quantity being measured; 
• Selectivity: property of a measuring system, used with a specified measurement pro-
cedure, whereby it provides measured quantity values for one or more measurands 
such that the values of each measurand are independent of other measurands or other 
quantities in the phenomenon, body, or substance being investigated; 
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• Dynamic range: interval between the minimum and maximum concentration of a 
quantity being measured in which the sensor is sensitive; 
• Linear range: values between which the output signal is directly proportional to the 
input signal; 
• Limit of detection (LOD): minimum value discriminated by the sensor; 
• Stability: property of a measuring instrument, whereby its metrological properties 
remain constant in time; 
• Response time: duration between the instant when an input quantity value of a meas-
uring instrument or measuring system is subjected to an abrupt change between two 
specified constant quantity values and the instant when a corresponding indication 
settles within specified limits around its final steady value; 
• Recovery time: amount of time until the sensor can take a new measurement; 
• Accuracy: closeness of agreement between a measured quantity value and a true 
quantity value of a measurand; 
• Calibration curve: expression of the relation between indication and corresponding 
measured quantity value [14], [15].  
 The sensors can be classified according to their measurand. In this case, we speak of 
sensors for temperature, pressure, flow, level, humidity, pH, chemical composition, position, ve-
locity, acceleration, and so forth [16], [17].  
2.5 Paper  
 Paper was discovered in China, by the imperial court official Ts’ai Lun, back in A.D. 
105. He joined mulberry and other fibres with fishnets, old rags and hemp waste to produce the 
first sheet of paper. After the paper technology spread to the middle east, it suffered an improve-
ment by the Arabs, in which it was enhanced with linen, flax and other vegetable fibres. After the 
printing invention, the demanding for paper increased and nowadays paper is used in numerous 
areas, such as agriculture, building, business, cars, communications, domestic products, educa-
tion, electrical, entertainment, filtration, impregnated papers, industry, medical and finances [18], 
[19]. 
 Paper is mostly constituted by cellulose, which is one of the most abundant biopolymers 
on earth and has various benefits such as low cost, availability, renewability, light weight, na-
noscale dimension and unique morphology [20]. This polymer can have different origins, such as 
wood pulp, bacteria, cotton or other plant fibres and is composed by aldehyde sugars [21]. Each 
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cellulose chain is asymmetric, with a chemically reducing end and a nonreducing end that con-
tains a pendant hydroxyl group. These chains come together, by van der Waals forces, intra-mo-
lecular and inter-molecular hydrogen bonds, to form cellulose fibres. This hydrogen-bonding and 
the molecular orientation can vary widely, originating different cellulose polymorphs. The cellu-
lose chemical structure is present in Figure 2.6.  
 
Figure 2.6 Cellulose chemical structure 
[22] 
 A parameter termed the crystalline index (Cr.I.) has been used to describe the relative 
amount of crystalline material in cellulose [23]. This parameter can be calculated by the empirical 
method proposed by Segal [24]: 
𝑪𝒓. 𝑰. (%) =
𝑰𝟐𝟎𝟎−𝑰𝒂𝒎
𝑰𝟐𝟎𝟎
× 𝟏𝟎𝟎    (2.1) 
where I200 is the maximum intensity of the (200) lattice diffraction and Iam is the intensity diffrac-
tion at 18º 2Ɵ degrees. Native cellulose or cellulose I is the most crystalline type and presents 
two forms Iα and Iβ. In both structures, the hydrogen-bonding patterns differ, resulting in different 
crystalline structures. The first has a triclinic unit cell, while the second has a monoclinic unit 
cell. The ratio in native cellulose depends on their source: cellulose from bacteria and algae have 
mainly Iα, while higher plants present both Iα and Iβ [20], [21]. 
 The use of paper as diagnostic support in sensors contains several benefits, such as the 
price, the high surface to volume ratio, the large supply with different formats and properties, the 
compatibility with various chemicals, the disposability, the easy use and the presence of a white 
background, which allows a colorimetric detection [25]. The colorimetric detection in paper de-
vices involves the movement of the analyte to the test zone, through capillary force, where it 
interacts with specific reagents. This produces a colour that can be analysed at naked eye or 
through additional equipment. This colorimetric detection can be performed using metal nano-
particles [26]. 
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2.6 Microfluidics 
Microfluidics involve the use of devices on a microscale that allow accurate manipulation 
of small volumes of fluids. This presents advantages such as reduced use of reagents and products, 
speed, reduced size, precise temperature control, low energy consumption, low risk of contami-
nation and low-cost mass production. Microfluidic devices are well suited for medical diagnostic 
tests performed outside the laboratory and with the patients, namely Point-of-Care (POC) tests 
[27]. According to WHO the POC devices must be affordable, sensitive, specific, user-friendly, 
rapid and robust, equipment-free and deliverable to those in need [25], [28]. 
 The manufacture of microfluidic devices consists in the production of channels on the 
surface of a solid substrate, in the formation of small holes to allow the entrance of the fluids, and 
in the encapsulation of the device. One of the methods most used for its manufacture is the soft 
lithography [29], which consists of the engraving of patterns in a soft polymer such as polydime-
thylsiloxane (PDMS) [30]. 
 Microfluidics on paper was introduced by the Whitesides group of Harvard University in 
2007. It was presented as an inexpensive device with the possibility of being considered a POC 
equipment. This Lab-on-Paper technology consists in the creation of microchannels on hydro-
philic paper limited by hydrophobic polymers, wax or photoresist (light-sensitive material). The 
technology for standardizing paper that allows a better production-cost ratio is wax printing. In 
this technique, the paper is patterned with solid hydrophobic wax and then heated to melt and 
diffuse through the pores of the paper. This allows the creation of hydrophobic barriers that de-
limit the hydrophilic channels, the reaction zones and the fluid reservoirs [25].  
2.7 Gold Nanoparticles 
Nanoparticles are defined as particles ranging from 1 nm to 100 nm. These particles have 
very particular chemical and physical characteristics, namely chemical surface, size, shape-de-
pendent electronics and optical properties [31]. Due to these characteristics, the nanoparticles can 
be used as biological and chemical sensors for detection of analytes [32]. 
 Some of the nanoparticles with the most applications in the biomedical area are the gold 
nanoparticles (GNPs). These nanoparticles when present in solution, have a reddish colour with 
a maximum absorption peak at 562 nm [32], [33]. The position of the absorption peak depends 
on the shape and state of aggregation of the particle. The broadness of the peak provides infor-
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mation on particle size distribution and state of aggregation. Its intensity of absorption is propor-
tional to the number of nanoparticles produced [33], [34]. When aggregated, GNPs show changes 
in colour and maximum absorption peak position [32]. 
The colour change of GNPs is related to surface plasmon resonance (SPR) of nanoparti-
cles (Figure 2.6) [35]. This phenomenon consists of the collective oscillation of free electrons in 
resonance with the incident electromagnetic radiation [36]. As the wave front of the radiation 
passes, the electron density in the particle is polarized to one surface and oscillates in resonance 
with the radiation’s frequency, causing a standing oscillation [37]. The frequency of this phenom-
enon depends on the size and shape of the nanoparticle, the dielectric properties of the medium 
and the coupling interactions between nanoparticles [35]. As the shape or size of the nanoparticle 
changes, the surface geometry also changes, causing a shift in the electric field density on the 
surface and consequently, a change in the oscillation frequency [37]. For small spherical mono-
disperse GNPs, the SPR phenomenon causes an absorption of light in the blue-green region of 
the spectrum, dispersing red light. For increased size particles the wavelength of SPR shifts to 
higher values, absorbing red light and dispersing blue/purple light. As the particle size continues 
to increase, the SPR wavelengths shifts to the infrared region and the GNPs acquire a translucent 
colour [38]. When spherical GNPs aggregate, they increase the total particle size, leading to a 
colour change in the solution from red to blue. Due to the colour change of the GNPs, these can 
be used for colorimetric detection in sensors. In addition to this feature, GNPs are inexpensive, 
easy to prepare and allow quick and effective detection [32]. 
 
Figure 2.7 Localized surface plasmon resonance 
Light interacts with particles much smaller than the incident wavelength, which leads to a plasmon that 
oscillates locally around the nanoparticle with a frequency known as localized surface plasmon resonance. 
[39] 
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3 State of the Art 
 The purpose of this chapter is to introduce the different methods for detection of falsified 
antibiotics in more and less developed countries. Examples of microfluidic paper-based analytical 
devices are presented to contextualize this theme with methods already developed to evaluate the 
purity of -lactam antibiotics. 
3.1 Methods for detection of falsified antibiotics 
 A variety of technologies have been used to detect falsified and substandard antibiotics. 
Qualitative tests demonstrate the presence or absence of the API while quantitative tests ensure 
that the API is present in the correct dosage. The range of technologies include colorimetry, chro-
matography, spectroscopy, X-ray diffraction and spectrometry [4], [40], [41]. The gold standard 
procedure to detect counterfeit antibiotics is via High-performance liquid chromatography 
(HPLC) and Mass Spectrometry (MS). 
 Chromatography allows the separation of different ingredients in a mixture by their in-
teraction with a solid stationary phase, fixed in a column or support. Each compound of the mix-
ture interacts with the stationary phase through a mobile phase and acquires different speeds de-
pending on its affinity. As many compounds are colourless in the UV/Visible range, specific de-
tectors based on refraction index changes, fluorescence or absorbance at various wavelengths, are 
used to reveal them. In HPLC the sample is dissolved in a solvent and pumped at high pressure 
through a column with silica particles [42]. This technique allows the separation, identification 
and precise quantification of the API in non-volatile samples, through ultraviolet-visible light 
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absorbance detectors and mass spectrometers. Gas chromatography is used to detect volatile com-
ponents, residual solvents and undeclared ingredients. This technique is similar to HPLC except 
for the mobile phase, that is in a gaseous state [43], [44]. These procedures are sophisticated and 
efficient however they require expensive laboratory instruments.  
 MS allows the identification of the compounds present in an antibiotic based on their 
charge and mass. Different compounds exposed to an external electric field acquire different ve-
locities or require different electric fields to be moved, which allows their identification. The 
results are compared with results obtained by standard samples under the same conditions [42]. 
It is a specific and precise technique that does not require a sample preparation yet, it is expensive 
and requires specialized people for the procedure [4]. 
 X-ray diffraction can be used to analyse the physical and chemical characteristics and the 
structural orientation of the API and the excipients of an antibiotic. The X-rays focus on the sam-
ple and specific diffraction patterns are formed, which reflect the characteristic physical and 
chemical properties of each component. The specific pattern of a drug is a superposition of all the 
diffraction patterns from its crystalline components. Any change in the drug can be identified 
after comparison with the genuine drug. This technique has the disadvantage of requiring a skilled 
person, having to be performed in a laboratory, and being less sensitive and reliable than HPLC 
and MS [45], [46]. 
 Microbiological assays can determine the bioactivity and potency of an antibiotic. These 
assays are performed on bacterial cultures and involve the evaluation of the biological response 
of bacteria to the antibiotic. They have the disadvantage of also having to be carried out in a 
laboratory, being longstanding and susceptible to errors, due to various factors such as incubation 
temperature, sample preparation and agar layer thickness [47]. 
 As the presented techniques require expensive equipment, specialized technicians or suit-
able infrastructures, it is difficult to use them in less developed countries. Consequently, drug 
efficacy and purity are determined by visual inspection, dissolution and disintegration assays, 
Thin-layer Chromatography (TLC), GPHF-Minilab, portable spectroscopy devices and colori-
metric techniques [4], [40], [41]. These techniques have the disadvantage of being less sensitive 
and less specific than the techniques used in developed countries. Although visual inspection of 
packaging and label quality is inexpensive and basic, without chemical analysis it is not possible 
to guarantee the purity of the drug, since most of the suppliers of these falsified products invest 
in the improvement of the packaging [1]. 
 Disintegration and dissolution assays consist of placing the tablet in water at a specific 
temperature. The first one verifies if the antibiotic disintegrates within the prescribed time and 
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the second one allows to evaluate the percentage of drug released in the medium and conse-
quently, evaluate the effectiveness of the drug. In the dissolution assay the drug is dissolved with 
the aid of a device which promotes constant agitation of the medium. The presence of incorrect 
excipients, poor manufacturing quality and poor storage conditions can lead to poor dissolution. 
Although the dissolution assay requires more training and more sophisticated equipment than the 
disintegration assay, both can identify a falsified drug even with the correct dosage of API [43].  
 In TLC, a small drop of sample is placed on a chromatographic plate which is then in-
serted into a solvent. The solvent moves through the plate by capillary forces and the different 
components of the sample acquire different rates of mobility, which allows their separation. The 
position of each component can be calculated by the ratio between the distances travelled by the 
component and the solvent [44]. Although it is a quick and inexpensive method, it has the disad-
vantage of requiring flammable or toxic reagents and trained people to perform the procedure. 
 The GPHF-Minilab is a quality control kit for medicines and is made up of laboratory 
equipment and chemical products that allow to carry out about a thousand tests. The quality check 
of the medicines by this kit involve physical inspection of the medicine and its packaging, a dis-
integration test and TLC tests [48]. It is a simple, reliable and inexpensive method but requires 
reagents, solvents, standard samples and trained people to perform it. 
 Spectroscopy involves the interaction between chemical compounds and electromagnetic 
radiation. When the sample is irradiated with a specific wavelength, the components of that sam-
ple absorb the energy and vibrate along its chemical bonds. The collection of these vibrations 
allows the chemical structure of the antibiotic and its constituents to be obtained. By comparing 
the specimens obtained with known specimen, it is possible to identify whether the antibiotic is 
falsified or not. In developed countries, various spectroscopy techniques have been shown to be 
efficient methods for the qualitative and/or quantitative analysis of antibiotic’s API and excipi-
ents. Portable Raman and infrared spectrometers allow the chemical information of and antibiotic 
to be obtained without having to take the sample to the laboratory, which is useful for less devel-
oped countries. However, these portable devices have a high initial investment, require a pre-
loading of a spectrum library and the presence of fluorescent material in the antibiotic may inter-
fere with the results [42], [43]. 
 Colorimetric techniques use the colour developed, due to the presence of reagents, to 
evaluate the presence or absence of specific components in the sample. The intensity of this colour 
allows qualitative information of these components to be obtained through specific devices or 
naked eye. These types of techniques can be performed by non-specialist and allow a rapid and 
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highly specific detection. Over the years, these tests have been improved and are now incorpo-
rated into microfluidic paper devices, making them inexpensive, equipment free and easy to use 
[3], [4], [42], [49].  
3.2 Paper-based devices for detection of falsified -lactam antibiotics  
In 2013, Weaver et al. [49] developed a paper analytical device for detecting the purity 
of -lactam antibiotics and anti-tuberculosis drugs. This device detects the APIs, such as ampi-
cillin, amoxicillin, rifampicin, isoniazid, ethambutol and pyrazinamide, screens for substitute 
pharmaceuticals, such as acetaminophen and chloroquine, and can detect binders and fillers like 
chalk, talc and starch. It consists of twelve hydrophilic channels separated by hydrophobic barri-
ers standardized with wax. Each channel contains different deposited reagents that allow the iden-
tification of the different components present in the drug. Of the twelve channels, five are to test 
the presence of functional groups expected to appear in the targeted antibiotics, six are to test the 
presence of excipients and substitute materials, and the other channel is to indicate when the de-
vice can be withdrawn from the water. The drug is spread over a line about 1-1.5 cm below the 
top of the channels, depositing at least 0.5000 mg of the solid in each channel. Once the sample 
is applied, the device is set in water and held upright for about four minutes. The water rises 
through the channels by capillary forces and different chemical reactions occur. These reactions 
cause the device to form a coloured bar code (Figure 3.1), which is then compared with standard 
samples. For optimal colour development, the device should dry flat for five minutes [49]. 
Some of the colorimetric indicators used in this device are copper (II), ninhydrin, iron 
(III) chloride, tosic acid, sodium nitrate, nitroaniline, sodium hydroxide, tri-iodide ion, nickel (II) 
and nioxime. Copper (II) acquires a dark forest green coloration in the presence of -lactam an-
tibiotics. Ninhydrin is used to discriminate between ampicillin and amoxicillin. It acquires an 
orange coloration in the presence of ampicillin and a forest green coloration in the presence of 
amoxicillin. The purpose of iron (III) chloride is to indicate the presence of adulterants such as 
baking soda, chalk or calcite. The channel to evaluate the presence of the phenol functional group, 
found in amoxicillin and ampicillin, and the presence of acetaminophen, contains four reagents: 
tosic acid, sodium nitrate, nitroanline and then sodium hydroxide. As the water moves up, the 
reagents successively mix and form an unstable acid, which gains a strong orange colour in the 
presence of amoxicillin, ampicillin or acetaminophen. The channel with tri-iodide Ion is used to 
detect starches and the channel with nickel (II) and nioxime serves as a timer. An intense pink 
spot is formed when the nioxime reaches the nickel (II), which indicates to the user that the device 
should be removed from the water[49].  
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The device was tested with multiple samples containing pure API, combinations of API 
and pure excipients. To simulate falsified drugs, the device was tested with samples of ampicillin 
with 50% of powder talc and samples with substitute API, such as acetaminophen. This pharma-
ceutical screening test does not require a lab and allows a qualitative analysis of the presence of 
API, common drug substitutes and unapproved excipients. A batch of sixty paper analytical de-
vices can be made start to finish in under two hours and the cost per device is about $0.45 [49]. 
It has the disadvantage of not allowing a quantitative analysis. 
 
Figure 3.1 Paper analytical device for detecting the purity of amoxicillin and ampicillin 
Each channel contains different deposited reagents that allow the identification of the different components 
present in the drug. Of the twelve channels, five are to test the presence of functional groups expected to 
appear in the targeted antibiotics, six are to test the presence of excipients and substitute materials, and the 
other channel is to indicate when the device can be withdrawn from the water [49]. 
 In 2018, Boehle et al. [3] developed another paper-based assay for detecting falsified -
lactam antibiotics. This device is based on an enzyme competition that uses nitrocefin, a chromo-
genic substrate, to compete with -lactam antibiotics in a reaction with -lactamase. Nitrocefin 
is hydrolysed in the presence of -lactamase, which leads to a change of colour from yellow to 
red and allows a colorimetric detection. This device contains a section for antibiotic purity detec-
tion and another section for pH detection, both standardized with wax (Figure 3.2). -lactamase 
is deposited in the antibiotic purity analysis detection zone and nitrocefin is placed along the 
channel. By dissolving the antibiotic in water and adding it to the device, the solution moves by 
capillary forces to the detection zone, which allows its passage through the dried nitrocefin. If the 
APIs are present in the solution they will compete, in a concentration dependent manner, for the 
-lactamase active site with the dilute nitrocefin. In the case of a legitimate antibiotic, the API is 
at higher concentration than nitrocefin, so the detection zone remains yellow. In the case of a 
counterfeit antibiotic, there is a higher concentration of nitrocefin to react with -lactamase and 
the detection zone turns red. The channel for pH detection is subdivided into three channels with 
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different pH indicators, namely bromophenol blue, phenol red and phenolphthalein. Bromophe-
nol blue is used to indicate acidic pH values, phenol red indicates values between pH 6 and pH 8 
and phenolphthalein indicates alkaline pH values. The pH indication zone can alert the user when 
the assay is at an acidic or alkaline pH [3]. 
The device was printed on Whatman chromatography paper using a ColorQube 8870 wax 
printer and then placed on a hot plate and covered with a metal plate at 165 ºC, for 90 s, to allow 
the wax to melt through the paper pores. The sample was then added to the sample inlet and the 
device was left to react for 15 min before scanning and image analysis. To test common drug 
replacements, 50 mg mL-1 solutions were made of each falsified replacement (chalk, gelatine, 
sodium bicarbonate, acetylsalicylic acid, sucrose, D-(+)-lactose and calcium carbonate) and dis-
solved in water. Because the enzymatic reaction between nitrocefin and -lactamase is pH de-
pendent, the device only works optimally between pH 6.5 and pH 8 and does not work at acidic 
pHs, which can be a disadvantage [3]. The fact that this device uses -lactamase for its function-
ing, does not allow a quantitative analysis of -lactamase inhibiting penicillins, because the pres-
ence of these inhibitors can affect the assay. Other disadvantages are the storage and the enzy-
matic activity of the device. To store nitrocefin for more than one week, the device must be stored 
in a refrigerator, which might not be possible in some areas. Also, -lactamase loses its enzymatic 
activity over time, affecting the life shelf of the device.  
 
Figure 3.2 Operation of the paper device developed by Boehle et al. 
The pH indicator section contains 0.45 μL of bromophenol blue (1), 0.30005 μL of phenol red (2) and 0.40 
μL of phenolphthalein (3). The antibiotic purity detection section contains 2.5 μL of -lactamase (4) and 2 
μL of nitrocefin (5). 35 μL of sample is added to the sample inlet and allowed to saturate and react with the 
device. The fluid wicks down the channel, rehydrating and transporting the stored nitrocefin to the detection 
zone to react with -lactamase. If the sample contains API, it should be present at a higher concentration 
relative to nitrocefin, therefore -lactamase will react with the antibiotic and the device will stay yellow. If 
the sample is falsified and does not contain API, nitrocefin will be the dominant substrate, resulting in a 
distinct colour change from yellow to red [3]. 
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 The device designed in this thesis has several advantages over the previous devices. It 
allows a quantitative analysis, it can be used by -lactamase inhibiting penicillins and it is non-
enzymatic which improves the life shelf of the sensor and its resistance to storage and transport 
conditions. 
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4 Materials and Methods 
 In this chapter, the methods and experimental procedures used in this thesis for the sens-
ing of falsified antibiotics in solution and paper substrate are described. These procedures are 
based on the one-step reduction of the gold salt by antibiotics, which synthesize stable antibiotic 
conjugated GNPs. The synthesis of these GNPs in solution and on paper substrate are presented, 
as well as the validation tests of the sensor with common materials found in falsified antibiotics 
and the characterization of two different types of paper, to help choose the best substrate for the 
device. In addition, the fabrication of the final device and its cost are also presented. 
4.1 Materials 
 Gold (III) chloride trihydrate (HAuCl4 ∙ 3H2O), ceftazidime hydrate (C22H22N6O7S2 ∙ 
xH2O), ampicillin trihydrate (C16H19N3O4S ∙ 3H2O), amoxicillin trihydrate (C16H19N3O5S ∙ 3H2O), 
Sodium Bicarbonate (NaHCO3), D-(-)-fructose (C6H12O6) and D-(+)-galactose (C6H12O6) were 
purchased from Sigma-Aldrich. Gelatine was purchased from Merck and calcium carbonate, pre-
cipitated, extra pure (CaCO3) was purchased from Scharlau. All chemicals were used without 
further purification. Migraspirina (acetylsalicylic acid (C9H8O4), 500 mg) was manufactured by 
Bayer, lot #BT10JT1, expiration date 11/2021. 
4.2 Synthesis of GNPs in solution  
 The experimental procedure for the synthesis of colloidal GNP solutions was based on 
the study conducted by M. Demurtas and C. C. Perry, that consists on the synthesis of stable 
antibiotic conjugated GNPs by a one-step reaction using amoxicillin. The amoxicillin reduces the 
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gold salt to form nanoparticles and at the same time coats them to afford the functionalised nano-
material [33]. In this thesis, 1447 µL of distilled water, 15 µL of HAuCl4 ∙ 3H2O (0.010 M) and 
38 µL of amoxicillin trihydrate at different concentrations were added to a 1.5 mL Eppendorf 
tube in this order. The Eppendorf tubes with different concentrations of antibiotic (1.0000 mM, 
0.5000 mM, 0.3000 mM, 0.2500 mM, 0.1300 mM, 0.1000 mM, 0.06500 mM, 0.0325 mM and 
0.0100 mM) were placed open in a 70º C water bath for 15 minutes. The same procedure was 
performed for ceftazidime hydrate and ampicillin trihydrate. The duration of this procedure in 
water bath was based on another dissertation developed in CENIMAT|i3N [50]. 
 To verify if this reaction occurs without the heat source, the same procedure was done 
with the Eppendorf tubes left at room temperature for 24 hours, for the three antibiotics. The 
duration of this procedure was based on the study conducted by A. Rai, A. Prabhune, and C. C. 
Perry, that consists on the reduction of gold ions using cefaclor at 20 ºC, during 24 hours [51]. 
4.3 Synthesis of GNPs on paper substrate 
 Office paper was used as substrate to produce paper microplates with 384 wells (3.38 cm 
diameter) for the synthesis of GNPs. These microplates, represented in Figure 4.1, were produced 
using the Lab-on-Paper technology developed by CENIMAT|i3N [50]. As mentioned in chapter 
2, Lab-on-Paper technology consists in the formation of hydrophilic microchannels delimited by 
hydrophobic barriers. The microplates were designed on Adobe Ilustrator software and printed 
on A5 office paper using the Xerox ColorQube 8570 printer (Figure 4.2 - A). In this printer, the 
solid cartridge wax is melted before being ejected and thereafter solidifies on the paper surface, 
instantly. This technology reduces the waste of material, since these wax cartridges can be reused 
to form new cartridges. After wax paper is standardized, it is placed on a SCHOTT ROBAX heat-
ing plate (Figure 4.2 - B) at 120º C, during 2 minutes, to allow the vertical diffusion of the wax 
through the pores of the paper [25].  
 The procedure for the synthesis of GNPs on paper substrate consists on the deposition of 
HAuCl4 ∙ 3H2O followed by the deposition of antibiotic solutions in each well, without letting the 
HAuCl4 ∙ 3H2O dry. After this, the paper can dry at room temperature. The optimum volumes of 
HAuCl4 ∙ 3H2O and antibiotic to use are 4 µL and 9 µL, respectively. The optimum HAuCl4 ∙ 
3H2O concentration to use is 0.010 M for amoxicillin trihydrate and ampicillin trihydrate, and 
0.006 M for ceftazidime hydrate. 
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Figure 4.1 384-microplate design 
 
 
Figure 4.2 Devices used on the production of the paper microplates 
A: Xerox ColorQube 8570 printer used to print the paper microplates; B: SCHOTT ROBAX heating plate 
used to diffuse the wax through the pores of the paper. Adapted from [52], [53]. 
4.4 Testing common drug replacements 
 Selected falsified ingredients (gelatine, sodium bicarbonate, acetylsalicylic acid, calcium 
carbonate [3], D-(-)-fructose and D-(+)-galactose) were used in the previous procedures instead 
of the antibiotics, to see if there was still formation of GNPs. Each ingredient was dissolved in 
distilled water to obtain solutions with the concentrations of the antibiotics previously used. 
 To obtain the acetylsalicylic acid solution, a tablet of Migrosapirina was grinded with 
the help of a mortar and pestle and it was considered that each tablet contained 500 mg of acetyl-
salicylic acid. As the molecular mass of the gelatine is unknown, the molar concentrations were 
obtained by approximation to the ceftazidime molar concentrations. The molar concentrations of 
ceftazidime previously used were converted to mass concentrations and served as guides for the 
preparation of the gelatine solutions. In other words, the mass concentrations used for gelatine 
were the same as the obtained mass concentrations of ceftazidime. These values and methods of 
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calculation are demonstrated in Annex A. As calcium carbonate has a solubility in water of 14 
mg/L at 25º C, the solutions were only prepared with concentrations between 0.1300 mM and 
0.0100 mM. To dissolve the gelatine, it was necessary to heat the solution up to 60º C and for this 
compound, only concentrations between 0.0325 mM and 1.0000 mM were used. 
4.5 Characterization Methods 
 The purpose of this phase is to evaluate the size, shape and concentration of the GNPs 
produced in the previous phases and observe the differences between the Whatman No.1 chro-
matography paper and the office paper, in order to decide the best paper substrate for the final 
device. To characterize the GNPs synthesized in solution, UV-Vis spectrophotometry was used 
and to evaluate the GNPs synthesized on paper substrate, ImageJ software and Scanning Electron 
Microscopy (SEM) were used. To characterize the two types of paper, various characterization 
techniques were used, such as SEM, Fourier Transform Infrared Spectroscopy (FTIR), X-Ray 
Diffraction (XRD), Thermogravimetry (TG) and Differential Scanning Calorimetry (DSC). 
4.5.1 UV-Vis spectrophotometry 
 UV-Vis spectrophotometry is based on the absorption of light by a sample. The sample 
is illuminated with electromagnetic rays of various wavelengths, in the visible and ultraviolet 
range of the spectrum, and the recording of the absorption spectra is achieved by a spectropho-
tometer. This equipment measures the intensity of the light that passes through the sample solu-
tion and compares it to the intensity of the initial light. This light is partially absorbed by the 
sample molecules in the solution. The quantity of light and its wavelength absorbed by the sample 
provides information that can be used to identify or quantify each substance. UV-Vis spectra 
allow the identification of the components present in the sample solution, by the position and 
profile of the absorption peaks [54]. In this thesis, this technique was used to confirm the existence 
of GNPs in the solutions, characterize the optical properties of the GNPs, and analyse possible 
changes in size and concentration resulting from the reactions. A TECAN SPARK 10M spectro-
photometer was used to measure the absorbance of the solutions in each well of the microplate. 
The absorbance of a material (A) s given by: 
𝐴 =  log 𝑇 =  log
𝐼
𝐼0
               (4.1) 
Where T is the transmittance of that material, I is the radiant flux transmitted and I0 is the radiant 
flux received by that material. A microplate well with only water was use as reference and is 
represented in Figure 4.3. 
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Figure 4.3 UV-Vis spectrophotometry analysis of a microplate well with only water 
4.5.2 ImageJ software 
 ImageJ software is an image processing program that can display, edit, analyse, process, 
save and print images. It can also calculate areas and pixel values, measure distances and angles, 
create density histograms and perform geometric transformations [55]. This software was used in 
this thesis to extract the RGB (Red - Green - Blue) channel intensities of each paper microplate 
well, in order to calculate the ratio between Red and Green channels. This ratio was used to plot 
a calibration curve that relates the Red/Green Ratio of the well with each antibiotic concentration 
and allows the antibiotic API dose calculation. Each paper microplate was first scanned by a 
Canon MG5250 scanner, in TIF format and with a 600 dots per inch resolution, in order to 
standardize the colour representation and the number of pixels for each paper microplate well.  
4.5.3 Scanning Electron Microscopy 
 SEM is a technique that allows large magnifications to be made on sample surfaces, in 
order to obtain the morphology, microstructure and topography of its surface. The sample surface 
is bombarded with an electron beam and radiation is emitted, allowing for high resolution images, 
a digital display of absorbed electrons, an elemental chemical analysis and a chemical distribution 
mapping. Image formation is dependent on the acquisition of signals produced from the electron 
beam and specimen interactions, such as elastic and inelastic interactions. The elastic interactions 
are characterized by an insignificant energy loss during the collision and by a wide-angle direc-
tional change of the scattered electron. In the inelastic interactions the electron beam transfers 
substantial energy to the atom, which leads to the excitation of the specimen electrons and the 
generation of secondary electrons. These secondary electrons can be used for topographic contrast 
for visualization of surface texture and roughness. The topographical image depends on the num-
ber of secondary electrons that reach the detector. The electrons that don’t reach the detector will 
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generate shadows or a darker contrast than the regions that have an unobstructed electron path. 
The SEM present in CENIMAT|i3N is a Zeiss AURIGA CrossBeam FIB-SEM and has a magni-
fication of 5x to 3000 000x and a resolution of 3.5 nm [56]–[58]. This technique was used in this 
thesis to characterize the morphology of the two different types of paper. The images were taken 
in secondary electron mode, with an electron high tension of 5 kV, an aperture size of 30 µm and 
a 6.2 mm distance between the sample and the SEM column.  
4.5.4 Fourier Transform Infrared Spectroscopy 
 FTIR is a technique used to identify the functional groups in the materials, by using a 
beam of infrared radiations. The infrared radiation is bombarded on the sample, which absorbs 
the light and creates various vibration modes. There are two modes of vibrations, namely stretch-
ing and bending vibrations. Stretching vibrations lead to an increase or decrease of the length of 
the bond, while bending vibrations cause a change in the bond angles and in the relative position 
of the atoms. Each infrared radiation frequency is absorbed by a bond in the molecule, due to the 
natural vibrational frequency of each bond, allowing the identification of the different functional 
groups present in the sample. The resultant spectrum is plotted in absorbance or % transmittance 
versus wavenumber (cm-1) in the infrared region [59]. In this thesis, this technique was applied in 
the characterization of the two types of paper used for the synthesis of the GNPs. To do so, a 
Nicolet 6700 from Thermo Electron Corporation was used, with Attenuated Total Reflectance 
configuration and the spectra were obtained in the spectral region of 525 to 4500 cm-1. 
4.5.5 X-Ray Diffraction 
 XRD is a non-destructive technique that allows the analysis of crystalline materials by 
providing information on structures, phases, preferred crystal orientations and structural parame-
ters, such as average grain size, crystallinity, strain and crystal defects [60]. It is based on con-
structive interference of monochromatic X-rays and a crystalline sample and consequently, a dif-
fracted ray that is detected, processed and counted. When the total incident X-ray pattern on the 
sample satisfies Bragg’s law, constructive interference occurs and a peak in intensity appears. 
Conversion of the diffraction peaks to d-spacings allows identification of the compound, by com-
parison with standard reference patterns [60]. For this project, a X’Pert PRO MPD system from 
PANalytcal was used to structurally characterize the different types of paper and the diffracto-
grams were obtained for angles between 10º and 90º (2Ɵ), with a scan step size of 0.03º, in con-
tinuous mode and operating at 45 kV with 40 mA. 
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4.5.6 Thermogravimetry and Differential Scanning Calorimetry 
 DSC determines the temperature and heat flow associated with material transitions as a 
function of time and temperature. During a change in temperature, DSC measures a heat quantity, 
radiated or absorbed excessively by the sample, calculated by the difference between the sample 
and material temperatures [61]. TG is a technique in which the mass of a substance is monitored 
as function of temperature or time, as the sample is subjected to a controlled temperature and 
atmosphere [62]. This technique provides information about physical and chemical phenomena 
and is used to detect evaporation, decomposition, oxidation and other effects of temperature al-
teration that cause mass changes. These techniques were used in this thesis to observe the re-
sistance of the different type of papers to heat, since the procedure of synthesis of GNPs on paper 
substrate uses a heating plate. The CENIMAT|i3N has a TGA-DSC STA 449 F3 Jupiter that can 
operate in a temperature range between room temperature and 1550 ºC and has a thermobalance 
that can measure samples up to 35g [63]. 
4.6 Fabrication of the final device 
 This phase consists of the production of an easy-to-use and intuitive paper-based platform 
for detecting counterfeit antibiotics. This device was developed by using the Lab-on-Paper tech-
nology previously mentioned. The sensor was designed on Adobe Ilustrator software and is rep-
resented in Figure 4.3, along with all its components. The front of the design includes the identi-
fication of the sensor, the test result and the date of realization, and the test zones. The production 
of the sensor includes the wax printing and heating of the front, to allow the wax diffusion, fol-
lowed by the wax printing of the back to encapsulate the device and prevent reagent loss between 
their deposition and drying. Figure 4.4 presents the sensor after wax diffusion. Along with this 
device, HAuCl4 ∙ 3H2O (0.010 M) and HAuCl4 ∙ 3H2O (0.006 M) will be provided for the test. 
Front Wells Back 
 
Figure 4.4 Prototype of the final paper-based sensor 
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Figure 4.5 Final paper-based sensor after wax diffusion 
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5 Results and Discussion 
 In this chapter, the results of the methods and experimental procedures used for the sens-
ing of falsified antibiotics, described in the previous chapter, are presented. These results include 
the study of optical properties of GNPs in colloidal solutions, the calibration curve for the final 
paper-based sensor and the validation tests, where common materials found in counterfeit antibi-
otics are tested on the paper substrate. The results obtained by the characterization of the two 
different types of paper to help choose the best substrate are also presented. 
5.1 Synthesis of GNPs in solution 
 For the synthesis of GNPs by the one-step reduction of a gold salt by antibiotics, various 
concentrations of antibiotic between 1.0000 mM and 0.0100 mM were tested, which correspond 
to diluted solutions of common amoxicillin dosages, such as 125 mg/5 mL, 250 mg/5 mL and 500 
mg/5 mL [64]. This process is based on the reduction of HAuCl4 by the antibiotics and is pre-
sented in Figure 5.1. The electrons are transferred from the amine group to the metal ion Au3+, 
resulting in the formation of Au0, which undergoes nucleation and growth to form GNPs. This 
reaction can occur in acidic or neutral solutions. “Amines are used extensively as reductants and 
subsequent capping agents in the synthesis of metal nanoparticles, especially gold, due to its af-
finity to nitrogen” [61]. Antibiotics with amine groups act as stabilizing and capping agents, pre-
venting aggregation [33], [51], [65], [66].  
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Figure 5.1 Reaction between HAuCl4 and the amine group present in the antibiotics and 
amoxicillin, ampicillin and ceftazidime structure 
The electrons are transferred from the amine group (present in the amoxicillin, ampicillin and ceftazidime 
structure) to the metal ion Au3+, resulting in the formation of Au0, which undergoes nucleation and 
growth to form GNPs [65]. 
 The resulting GNPs in solution (Figure 5.2), present a decrease of colour intensity with 
the decrease of antibiotic concentration. It is also verified that for lower concentrations of antibi-
otic the colour is almost imperceptible, indicating the non-formation of GNPs. To determine the 
relation between the amount of antibiotic and the optical properties of the synthesized GNPs, a 
UV-vis spectrophotometry analysis was performed with three repetitions for each condition.  
 
Figure 5.2 Colloidal GNPs solution obtained by gold salt reduction with antibiotics 
A: Amoxicillin; B: Ampicillin; C: Ceftazidime. 
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 Figures 5.3 - A, 5.4 - A and 5.5 -A represent the UV-Vis spectrophotometry analysis of 
the colloidal GNP solutions made at 70º C, upon addition of ampicillin, amoxicillin and 
ceftazidime, respectively. Figures 5.3 - B, 5.4 - B and 5.5 - B represent the calibration curves 
obtained by plotting the maximum absorbance with the corresponding antibiotic concentrations, 
using the mean and standard deviation values. The absorbance value used for the calibration curve 
plotting was the one corresponding to the approximated SPR peak position wavelength, which 
varied slightly for each antibiotic. 
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Figure 5.3 UV-Vis spectrophotometry analysis of colloidal GNP solutions upon addition of 
ampicillin 
A: Absorbance spectrum obtained upon addition of different concentrations of ampicillin; B: Correspond-
ing calibration curve of absorbance at 544 nm versus antibiotic concentration (n=3).  
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Figure 5.4 UV-Vis spectrophotometry analysis of colloidal GNP solutions upon addition of 
amoxicillin 
A: Absorbance spectrum obtained upon addition of different concentrations of amoxicillin; B: Calibration 
curve of absorbance at 548 nm versus antibiotic concentration (n=3). 
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Figure 5.5 UV-Vis spectrophotometry analysis of colloidal GNP solutions upon addition of 
ceftazidime 
A: Absorbance spectrum obtained upon addition of different concentrations of ceftazidime; B: Calibra-
tion curve of absorbance at 546 nm versus antibiotic concentration (n=3). 
 Analysis of Figures 5.3 - A, 5.4 - A and 5.5 -A show an increase in the absorbance value 
with the increase of antibiotic concentration used to synthesize the GNPs. In addition, it is possi-
ble to see that the lowest concentrations (0.0100 mM and 0.0325 mM) do not form GNPs. GNPs 
are characterized by an absorption peak in the visible region of the electromagnetic spectrum [33], 
so it can be concluded that the method used for synthesis of GNPs in solution is able to produce 
GNPs from 0.0650 mM. This establishes a LOD of 0.0650 mM of antibiotic concentration for 
synthesis of GNPs in solution, indicating that the antibiotic solution to test must have a concen-
tration above this value. Since the common dosages of amoxicillin are 125 mg/5 mL, 250 mg/5 
mL and 500 mg/5 mL, which correspond to approximately 0.046 M, 0.091 M and 0.183 M, re-
spectively, the dilution of the antibiotic must be performed to have a concentration between 
0.0650 mM and 1.0000 mM. 
 The SPR peak position provides information about the particle shape, the broadness of 
the peak indicates the particle size distribution and the state of aggregation and the absorption 
value is proportional to the amount of GNPs produced [33]. The absorbance peak varies from 
approximately 0.05 to 0.20 for ampicillin, 0.06 to 0.23 for amoxicillin and 0.05 to 0.23 for 
ceftazidime. These variations in absorbance and the number of GNPs produced are related to the 
antibiotic concentration. Ampicillin presents a lower absorbance value for the highest concentra-
tion than amoxicillin and ceftazidime, indicating that ampicillin produces less GNPs than the 
other antibiotics, in these conditions. It can also be observed, for the three samples, that for lower 
concentrations of antibiotic, the SPR peak absorptions are broader than for higher concentrations. 
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This indicates that higher concentrations of antibiotic form GNPs with narrower size distribution 
and aggregation.  
 Calibration curves from Figures 5.3 - B, 5.4 - B and 5.5 -B, which establish a relationship 
between the SPR peak and the antibiotic concentration, show that the absorbance value of the 
SPR peaks is directly proportional to the concentration of antibiotic up to 0.5000 mM. This con-
firms the increase of absorbance value with the increase of antibiotic concentration and indicates 
that the assay maintains the same sensitivity until the antibiotic concentration reaches 0.5000 mM.  
 Before applying this synthesis on paper substrate, the same procedure was done with the 
Eppendorf tubes left at room temperature for 24 hours, to see if this reaction occurs without the 
heat source. Figures 5.6, 5.7 and 5.8 represent the UV-Vis spectrophotometry analysis of the 
colloidal GNP solutions left at room temperature, upon addition of ampicillin, amoxicillin and 
ceftazidime, respectively.  
 Figures 5.6 - A, 5.7 - A and 5.8 – A, C show that the GNP synthesis occurs at room 
temperature in the same range of antibiotic concentrations as when synthesized at 70 ºC, that is 
from 0.0650 mM. The lowest concentrations (0.0100 mM and 0.0325 mM) do not form GNPs for 
these antibiotics, as in the previous cases. This maintains the LOD of 0.0650 mM of antibiotic 
concentration, for the synthesis of GNPs in solution at 70º C and at room temperature and con-
firms the concentration range in which the concentration of the antibiotic to test must be a part 
of. It can also be observed, for the three antibiotics, that for lower concentrations of antibiotic, 
the SPR peak absorptions are broader than for higher concentrations. This indicates that higher 
concentrations of antibiotic form GNPs with narrower size distribution and aggregation and was 
also seen in the samples left at 70º C. 
 In addition, it is verified that the absorbance value is higher for the cases of GNP synthesis 
left at room temperature than at 70 ºC, for ampicillin and amoxicillin. The SPR peak values varies 
from approximately 0.05 to 0.24 and from 0.06 to 0.40 for ampicillin and amoxicillin, respec-
tively. This corresponds to an increase of 0.04 for ampicillin and 0.07 for amoxicillin, when com-
pared to the results obtained at 70º C. Decreasing the reaction temperature during the reduction 
of HAuCl4 leads to a decrease in the rate of reduction. This provides a longer time for the inter-
action of the antibiotic with the HAuCl4 in the solution and leads to the production of more GNPs 
[33], [51]. In the case of ceftazidime, this does not occur. Ceftazidime is the antibiotic with the 
lowest maximum absorbance value (0.18), which is lower than when synthesized at 70º C (0.23), 
indicating that this antibiotic produces less GNPs when left at room temperature or that the reac-
tion was affected by environmental conditions. By increasing the reaction time between the gold 
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salt and the antibiotic to 24 hours, the sample also becomes more subjectable to changes in the 
lab conditions, such as temperature and light exposure, which might affect the reaction.  
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Figure 5.6 UV-Vis spectrophotometry analysis of colloidal GNP solutions upon addition of 
ampicillin and left at room temperature 
A: Absorbance spectrum obtained upon addition of different concentrations of ampicillin; B: Correspond-
ing calibration curve of SPR peak versus antibiotic concentration (n=3). 
 
 0.0100 mM
 0.0325 mM
 0.0650 mM
 0.1000 mM
 0.1300 mM
 0.2500 mM
 0.3000 mM
 0.5000 mM
 1.0000 mM
400 500 600 700 800
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.0 0.1 0.2 0.3 0.4 0.5
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
 
 
A
b
s
o
rb
a
n
c
e
Wavelength (nm)
B
 
 
A
b
s
o
rb
a
n
c
e
 m
e
a
n
Antibiotic Concentration (mM)
548 nm
Equation
Weight
Residual Sum 
of Squares
Pearson's r
Adj. R-Square
Absorbance me
Absorbance me
y = 0.04 + 0.001x
R
2
 = 0.99
B
 
Figure 5.7 UV-Vis spectrophotometry analysis of colloidal GNP solutions upon addition of 
amoxicillin and left at room temperature 
A: Absorbance spectrum obtained upon addition of different concentrations of amoxicillin; B: Calibration 
curve of SPR peak versus antibiotic concentration (n=3). 
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Figure 5.8 UV-Vis spectrophotometry analysis of colloidal GNP solutions upon addition of 
ceftazidime and left at room temperature 
A: Absorbance spectrum obtained upon addition of different concentrations of ceftazidime; B: Calibra-
tion curve of SPR peak versus antibiotic concentration (n=3); C: Zoom in the absorbance spectrum (A) at 
the lowest concentrations of ceftazidime. 
 From Figures 5.3 - B, 5.4 - B and 5.5 -B, it is possible to observe that the absorbance 
value of the SPR peaks of the UV-Vis spectrum is also directly proportional to the concentration 
of antibiotic, as in the GNPs synthesized at 70 ºC. This confirms the increase of absorbance value 
with the increase of antibiotic concentration. For ampicillin, the direct proportionality occurs up 
to 1.0000 mM of antibiotic concentration, instead of 0.5000 mM as in the synthesis at 70º C. This 
increases the range in which the assay maintains the same sensitivity, but only occurs for this 
antibiotic. Ampicillin is also the antibiotic with lower standard deviation values, which affects 
the average values of absorbance and consequently, the calibration curve. In addition, the adjusted 
R2 of the calibration curves is higher for GNPs synthesized at room temperature than at 70º C, 
indicating a better linear fit of the terms when synthesized at room temperature. The synthesis of 
GNPs on paper substrate can occur without the heat source. 
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5.2 Characterization of the paper substrates 
 In this thesis, two different types of paper were used as substrates (Whatman No.1 chro-
matography paper and office paper Portucel) in order to select the best fitted substrate for the 
paper-based sensor. The types of paper were submitted to different characterization techniques, 
mentioned in Chapter 4, to evaluate their properties. 
5.2.1 Scanning Electronic Microscopy  
 SEM was used to characterize and observe the morphology of the papers’ surface. SEM 
images of Whatman No.1 chromatography paper and office paper are represented in Figure 5.9 
and Figure 5.10, respectively. 
 
 
 
Figure 5.9 SEM images of Whatman No.1 chromatography paper with different magnifi-
cations 
A: 1000x magnification. B: 5000x magnification 
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Figure 5.10 SEM images of office paper with different magnifications 
A: 1000x magnification. B: 5000x magnification  
 Comparing the previous SEM images through visual inspection, it is possible to observe 
some similarities and differences in the morphology of their surfaces. Both substrates are mainly 
composed by a three-dimensional mesh of cellulose fibres. However, Whatman No.1 chromatog-
raphy paper presents a more cylindrical geometry and is more porous than the office paper. The 
office paper has flatter cellulose fibres, which gives it a lower thickness and higher density. It is 
also possible to detect small crystalline clusters in the office paper that are mainly calcium car-
bonate, a paper additive used to give higher opacity, brightness and smoothness. These agglom-
erates fill most of the pores, which makes the office paper less porous and with a more uniform 
surface. 
5.2.2 Fourier Transform Infrared Spectroscopy 
 FTIR was used to characterize and identify the functional groups present in the paper 
substrates. By observing the obtained FTIR spectra in Figure 5.11, it is possible to identify sev-
eral infrared peaks that are common to the office paper and the Whatman paper. These common 
peaks can also be found in the cellulose spectrum and are related to chemical bonds and functional 
groups present in the cellulose chemical structure, represented in Figure 5.12. In the first region 
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of the infrared spectrum, it is possible to identify three peaks: around 3300 cm-1, 2900 cm-1 and 
1600 cm-1. The peaks around 3300 cm-1 and 2900 cm-1 correspond to a hydrogen-bonded O-H 
stretch and a C-H symmetrical stretch, respectively. The other peak around 1600 cm-1 corresponds 
to the O-H bending of absorbed water [22], [67].  
 
Figure 5.11 FTIR spectra obtained for Whatman and office paper peak identification 
 
 
Figure 5.12 Cellulose chemical structure 
[22] 
In the fingerprint region, between 1500 cm-1 and 900 cm-1, it is also possible to identify 
cellulose characteristic peaks. The peak around 1400 cm-1 represents the CH2 and OH in-plane 
bending vibrations. Around 1150 cm-1, it can been observed a peak that represents the C-O-C 
asymmetric vibration, while around 1000 cm-1 there is another peak related to the C-OH side 
group vibration [22], [67]. The difference between the office paper and the Whatman No.1 paper 
is the presence of a CaCO3 band in the office paper, at 1420 cm-1, that corresponds to the calcium 
carbonate. This confirms that the small crystalline clusters detected in the office paper by SEM, 
are calcium carbonate. 
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5.2.3 X-Ray Diffraction 
 XRD was used to collect information about the structure of the different types of paper, 
by analyse of their crystalline materials. The diffractograms obtained for each type of paper are 
presented in Figure 5.13. 
 
Figure 5.13 XRD diffractogram obtained for Whatman and office paper 
 
 When analysing Figure 5.13, it is possible to observe that both types of paper present 
characteristic peaks of type I cellulose (native cellulose). However, Whatman paper has three 
diffraction peaks (14.93º, 16.60º and 22.88º) unlike the office paper that only has two diffraction 
peaks (15.97º and 22.82º). This is because “(…) Cellulose I has two polymorphs, a monoclinic 
structure Iβ and a triclinic structure Iα, which coexist in various proportions depending on the 
cellulose structure (…)” [24]. When the cellulose content is high, as in the case of Whatman 
paper, it is possible to observe two peaks near 15º, but when the fibre contains high amount of 
amorphous materials, such as lignin and hemicellulose, as in the office paper, these two peaks are 
smeared, appearing as one broad peak [24], [68]. Secondly, in the Whatman paper only one crystal 
structure was identified, as no more diffraction peaks are visible than the cellulose characteristic 
peaks. On the contrary, in the office paper other diffraction peaks are visible, which correspond 
to the crystalline structure of calcium carbonate [69]. This confirms the previous results obtained 
by SEM and FTIR. 
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 The crystalline index (Cr.I.) of each paper was calculated by the empirical method pro-
posed by Segal, mentioned in Chapter 2. Whatman paper, with an I200 of 22.80º, has a Cr.I. of 
approximately 74.37%, while office paper, with an I200 of 22.82º, has a Cr.I. of approximately 
69.17%. From these values, it is possible to confirm that Whatman paper has a higher cellulose 
content than the office paper. Whatman chromatography paper is manufactured from cotton lines 
with high percentage of cellulose, which guarantees quality, uniformity, a semi-crystalline struc-
ture and a higher degree of crystallinity [25]. 
5.2.4 Thermogravimetry and Differential Scanning Calorimetry 
 TG and DSC were used to study the behaviour of the office and Whatman No.1 papers 
when exposed to increased temperatures. During the procedure of synthesis of GNPs on paper 
substrate, the paper microplates are heated on a heating plate at 120 ºC, in order to melt and 
diffuse the wax through the pores of these substrates. Knowing the thermal properties of the final 
device’s substrate is important for its use, transport and storage. The DSC and TG curves of the 
two types of paper are represented in Figure 5.14. 
 
Figure 5.14 DSC and TG curves for Whatman and Office paper 
A: Whatman No.1 paper; B: Office paper 
 Observing the TG curves in Figure 5.14, it is possible to verify that there is a gradual 
mass loss until the temperature reaches approximately 100 ºC, corresponding to water evapora-
tion. The resultant mass loss is of approximately 4.54% for Whatman No.1 paper and 4.63% for 
office paper. From approximately 300 ºC to 360 ºC for Whatman paper and 250 ºC to 360 ºC for 
office paper, there is an abrupt mass loss, corresponding to cellulose degradation. At high tem-
peratures, cellulose decomposes very quickly and the products are released intensively within a 
short time interval [70]. The decomposition of cellulose results in a mass loss of approximately 
79.88% for Whatman paper and 49.13% for office paper. The mass loss is lower for the office 
paper, because of the presence of calcium carbonate that presents higher degradation tempera-
tures. The presence of two endothermic peaks during these temperature intervals (approximately 
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330 ºC and 370 ºC for Whatman paper and 273 ºC and 324 ºC for office paper), confirm the 
degradation of the cellulose due to thermal decomposition. From 360 ºC, the mass loss continues 
gradually. The cellulose degradation temperature, around 300 ºC, is distant from the temperatures 
used during the heating process in this thesis (120 ºC) and the possible conditions to which the 
final device will be exposed.  
5.3 Synthesis of GNPs on paper substrate 
 For the synthesis of GNPs by the one-step reduction of a gold salt by antibiotics on paper 
substrate, the same concentrations of antibiotic as the previous procedure (concentrations between 
0.0100 mM and 1.0000 mM) were tested. First this synthesis was done on Whatman No.1 chro-
matography paper (GE Healthcare), but this type of paper was discarded, because the colour 
appearance in the wells took approximately two weeks and the procedure was sometimes unpro-
ducible. As the purpose of this sensor is the rapid detection of falsified antibiotics and in the office 
paper there is an immediately visible colour change after the drying of the reagents, preference 
was given to the office paper for the substrate device. As observed in Section 5.2.1, Office paper 
has flatter cellulose fibres, a more uniform surface and is less porous than Whatman paper, which 
reduces the loss of gold salt by paper fibres.  
 Regarding the deposition of the reagents, first HAuCl4 ∙ 3H2O was deposited and allowed 
to dry at room temperature, and then the antibiotic was deposited. This procedure was unsuccess-
ful, and the wells would not acquire colour, so then the reagents were deposited sequentially, 
without letting the first one dry. Adding the antibiotic right after the deposition of HAuCl4 ∙ 3H2O 
and without letting it dry out, allows a greater diffusion and more homogeneous mixing of the 
reagents, improving the formation of GNPs.  
 To decide the optimum volumes and concentrations of HAuCl4 ∙ 3H2O and antibiotic, 
that allow the best distinction between the wells with antibiotic and the control well (addition of 
only HAuCl4 ∙ 3H2O), different volume ratios between these reagents and different concentrations 
of gold salt were tested. First the reagent volumes were varied with a fixed concentration of 
HAuCl4 ∙ 3H2O (0.010 M) and then different concentrations of HAuCl4 ∙ 3H2O were tested with 
the best two volumes previously obtained. In Figures 5.15, 5.16 and 5.17 it is possible to observe 
the results obtained after variation of the reagent volumes, using the fixed concentration of 
HAuCl4 ∙ 3H2O of 0.010 M. The volume ratio (HAuCl4:Amoxicillin) 3 µL:3 µL was based on 
previous projects carried out in CENIMAT|i3N and the volume ratio (HAuCl4:Amoxicillin) 3 
µL:7.5 µL was obtained through the volume ratio (HAuCl4:Amoxicillin) 15 µL:38 µL, used in 
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the synthesis of GNPs in solution. The other volume ratios were decided consonant with the best 
results obtained after two weeks on the Whatman No.1 chromatography paper. 
Volume ratio 
(HAuCl4:Amoxicillin) 
Amoxicillin Concentration (mM) 
0.0000    0.0100   0.0325   0.0650   0.1000  0.1300   0.2500  0.3000   0.5000  1.0000 
 
3 µL:7.5 µL 
 
 
3 µL:3 µL  
 
2 µL:7 µL 
 
 
4 µL:9 µL 
 
 
2 µL:8 µL 
 
Figure 5.15 Variation of the volumes of HAuCl4 ∙ 3H2O and amoxicillin 
Along the lines of the microplate varies the concentration of antibiotic from 0.0100 mM to 1.0000 mM 
and along the columns varies the volume ratio between the gold salt and the antibiotic. The first column 
of each line corresponds to the control well. 
 From Figure 5.15 it is possible to observe that the control wells do not present visible 
colour formation, indicating the non-formation of GNPs in the absence of antibiotic. In addition, 
the volume ratio (HAuCl4:Amoxicillin) 3 µL:3 µL is the one with less colour intensity in the 
wells. It is also the case in which less colour changes, perceptible to the naked eye, occur along 
the line. The volume ratios (HAuCl4:Amoxicillin) with higher colour intensity and better distinc-
tion when compared to the control well are 2 µL:7 µL and 4 µL:9 µL. These cases present an 
increase of colour intensity with antibiotic concentration, as in the GNP colloidal solutions. As it 
can also be seen through visual inspection, the resulting GNPs present a greyish colour instead of 
a red/pink colouration, indicating GNPs aggregation. In the volume ratios 2 µL:7 µL and 4 µL:9 
µL, it is possible to see a colour change, visible to the naked eye, from 0.0650 mM, indicating a 
LOD of 0.0650 mM for the synthesis of GNPs on paper substrate. This demonstrates that the 
LOD, for amoxicillin, is the same in the synthesis of GNPs in solution and on paper substrate. As 
common antibiotic dosages are 125 mg/5 mL, 250 mg/5 mL and 500 mg/5 mL and the protocol 
in this thesis is based on the dilution of the antibiotics, it is possible to dilute the solution to always 
be above the LOD. 
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Volume ratio 
(HAuCl4:Ampicillin) 
Ampicillin Concentration (mM) 
0.0000    0.0100   0.0325   0.0650   0.1000  0.1300   0.2500  0.3000   0.5000  1.0000 
 
3 µL:7.5 µL 
 
 
3 µL:3 µL 
 
 
2 µL:7 µL 
 
 
4 µL:9 µL 
 
 
2 µL:8 µL 
 
Figure 5.16 Variation of the volumes of HAuCl4 ∙ 3H2O and ampicillin 
Along the lines of the microplate varies the concentration of antibiotic from 0.0100 mM to 1.0000 mM 
and along the columns varies the volume ratio between the gold salt and the antibiotic. The first column 
of each line corresponds to the control well. 
 From Figure 5.16 it is possible to observe that ampicillin was the antibiotic that presented 
the least colour intesity in the wells, after reacting with the gold salt, and colour changes with the 
increase of antibiotic concentration.This is in line with the results obtained for the synthesis of 
GNPs in solution at 70º C, where ampicillin had lower absorbance values than amoxicillin and 
ceftazidime. This may be because of the presence of other reducing groups in amoxicillin and 
ceftazidime chemical structures, such as -OH and -COOH, that might improve the formation of 
GNPs on paper substrate [34], [71]. Most of the wells do not present visible colour formation and 
are not distinct from the control well, indicating the non-formation of GNPs. Only higher con-
centrations of ampicillin cause a slight colour change, when compared to the control well. The 
case that presents the most visible colour change with increasing antibiotic concentration, is the 
volume ratio (HAuCl4:Ampicillin) of 4 µL:9 µL. It is also the volume ratio in which there is a 
bigger difference between the intensity of the control well and the well with the highest antibiotic 
concentration. This volume ratio presents a LOD, visible to the naked eye, of 0.1000 mM, which 
is higher than the LOD for amoxicillin, decreasing the range in which the biosensor can work. 
This LOD is not so perceptible as in amoxicillin. 
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Volume ratio 
(HAuCl4:Ceftazidime) 
Ceftazidime Concentration (mM) 
0.0000    0.0100   0.0325   0.0650   0.1000  0.1300   0.2500  0.3000   0.5000  1.0000 
 
3 µL:7.5 µL 
 
 
3 µL:3 µL 
 
 
2 µL:7 µL 
 
 
4 µL:9 µL 
 
 
2 µL:8 µL 
 
Figure 5.17 Variation of the volumes of HAuCl4 ∙ 3H2O and ceftazidime 
Along the lines of the microplate varies the concentration of antibiotic from 0.0100 mM to 1.0000 mM 
and along the columns varies the volume ratio between the gold salt and the antibiotic. The first column 
of each line corresponds to the control well. 
 In Figure 5.17 it can be seen that the volume ratio (HAuCl4:Ceftazidime) 3 µL:3 µL is 
also the one with less colour intensity. The colour changes along the line, for this volume ratio, 
are almost imperceptible to the naked eye, as in Figure 5.15 Only higher concentrations of am-
picillin cause a slight colour change, when compared to the control well. The volume ratios 
(HAuCl4:Ceftazidime) with higher colour intensity and better distinction when compared to the 
control well are 3 µL:7.5 µL and 4 µL:9 µL. These also present an increase in colour intensity 
with the increase of antibiotic concentration. These resulting GNPs have a brownish/greyish col-
our instead of a red/pink colouration, indicating GNPs aggregation. The LOD, visible to the naked 
eye, in these cases is 0.0650 mM, for volume ratio 3 µL:7.5 µL, and 0.1.0000 mM, for volume 
ratio 4 µL:9 µL. As in the cases before, the protocol is based on the dilution of the antibiotics, so 
it is possible to dilute the solution to always be above the LOD. 
 In order to choose the optimum volume ratios between the gold salt and the antibiotic, 
preference was given to the cases with higher colour intensity and better distinction when com-
pared to the control well, and the cases in which the colour intensity of the wells increases with 
antibiotic concentration. It was also considered the R-squared and the properties of the calibration 
curve (colour signal vs. antibiotic concentrations) of each microplate line. For amoxicillin and 
ceftazidime two volume ratios were chosen while for ampicillin only one volume ratio was se-
lected, due to the low colour intensity and almost imperceptible colour change, along the micro-
plate line, for most of the different volume ratios.  
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 As mentioned before, to decide the optimum volumes and concentrations of reagents for 
the final device, first different volumes were tested with a fixed concentration of HAuCl4 ∙ 3H2O 
(0.010 M), then different concentrations of HAuCl4 ∙ 3H2O were tested with fixed volume ratios 
(gold salt:antibiotic). In Figures 5.18, 5.20, 5.22, 5.24 and 5.25 it is possible to observe the results 
obtained after variation of the concentration of HAuCl4 ∙ 3H2O, using the best volume ratios ob-
tained from the previous tables. Figures 5.18 and 5.20 were obtained using the best volume ratios 
for amoxicillin, Figure 5.22 was obtained using the best volume ratio for ampicillin and Figures 
5.24 and 5.25 were obtained using the best volume ratios for ceftazidime.  
5.3.1 Amoxicillin  
HAuCl4 
Concentration  
(M) 
Amoxicillin Concentration (mM) 
0.0000    0.0100   0.0325   0.0650   0.1000  0.1300   0.2500  0.3000   0.5000  1.0000 
 
0.006 
 
 
0.010 
 
 
0.02 
 
 
0.04  
 
0.1 
 
Figure 5.18 Variation of the concentration of HAuCl4 for the volume ratio 
(HAuCl4:Amoxicillin) of 4 µL:9 µL 
Along the lines of the microplate, varies the concentration of antibiotic from 0.0100 mM to 1.0000 mM 
and along the columns varies the concentration of HAuCl4 ∙ 3H2O. The first column of each line corre-
sponds to the control well, without antibiotic.  
 Figure 5.18 presents the results obtained after variation of the HAuCl4 concentration for 
the volume ratio (HAuCl4:Amoxicillin) of 4 µL:9 µL. It is possible to observe that as HAuCl4 
concentration increases, the number of wells with a visible grey colour formation decreases. In 
other words, as HAuCl4 concentration increases, the LOD visible to the naked eye also increases, 
decreasing the range in which the biosensor can work. At the lowest concentration of HAuCl4 
(0.006 M), the higher antibiotic concentrations no longer form a greyish colour after reacting with 
the gold salt, indicating that these concentrations do not form GNPs. The HAuCl4 concentrations 
which present a higher colour intensity and an increase of colour intensity with the increase of 
antibiotic concentration are 0.010 M and 0.02 M. The calibration curves of these two cases are 
presented in Figure 5.19 and the calibration curves of the rest of the cases are presented in Figure 
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B. 1 (in the Annex). These calibration curves relate the colour signal of each well with the anti-
biotic concentration and were obtained after image analysis through ImageJ software, based on 
the ratio between Red and Green channels. These calibration curves allows the antibiotic API 
dose concentration. 
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Figure 5.19 Calibration curves corresponding to Figure 5.18 
A: Calibration curve correspondent to HAuCl4 concentration of 0.010 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.02 M. 
 From Figure B. 1, it is possible to observe that the calibration curves correspondant to 
higher HAuCl4 concentrations have lower R-squared, indicating poorest fit of the terms. The cal-
ibration curves with higher R-squared are the calibration curves correspondent to HAuCl4 con-
centration of 0.010 M, 0.006 M and 0.02 M, which are presented in Figure 5.19 and Figure B. 
1. As the HAuCl4 concentrations with better visual properties on paper were 0.010 M and 0.02 M 
(Figure 5.19), preference was given to the case with HAuCl4 concentration of 0.010 M, due to a 
higher R-squared and lower standard deviations. As common antibiotic dosages are 125 mg/5 
mL, 250 mg/5 mL and 500 mg/5 mL and the protocol used in this thesis is based on diluted 
solutions of antibiotics, the user must dilute the antibiotic into solutions with concentrations in 
the range of antibiotic concentrations used in this protocol. 
 Figure 5.20 presents the results obtained after variation of the HAuCl4 concentration for 
the volume ratio (HAuCl4:Amoxicillin) of 2 µL:7 µL. As in the case obtained after variation of 
the HAuCl4 concentration for the volume ratio (HAuCl4:Amoxicillin) of 4 µL:9 µL, the HAuCl4 
concentration with better results is 0.010 M. It presents the highest colour intensity and the wells 
with better distinction when compared to the control well. The colour changes along the line, for 
the lowest HAuCl4 concentration (0.006 M), are almost imperceptible to the naked eye. For higher 
HAuCl4 concentrations than 0.010 M, only higher concentrations of amoxicillin cause a colour 
change, when compared to the control well. Considering the calibration curves of all the cases, 
the calibration curves with higher R-squared are the calibration curves corresponding to HAuCl4 
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concentration of 0.010 M and 0.02 M, which are presented in Figure 5.21. The calibration curves 
of the rest of the cases are presented in Figure B. 2 (in the Annex), where it is possible to observe 
that the calibration curves corresponding to higher HAuCl4 concentrations have lower R-squared, 
indicating poorest fit of the terms. Preference was given to the case with HAuCl4 concentration 
of 0.010 M, due to the better visual properties on paper and a calibration curve with higher R-
squared.  
HAuCl4 
Concentration  
(M) 
Amoxicillin Concentration (mM) 
0.0000    0.0100   0.0325   0.0650   0.1000  0.1300   0.2500  0.3000   0.5000  1.0000 
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Figure 5.20 Variation of the concentration of HAuCl4 for the volume ratio 
(HAuCl4:Amoxicillin) of 2 µL:7 µL 
Along the lines of the microplate, varies the concentration of antibiotic from 0.0100 mM to 1.0000 mM 
and along the columns varies the concentration of HAuCl4 ∙ 3H2O. The first column of each line corre-
sponds to the control well, without antibiotic.  
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Figure 5.21 Calibration curves corresponding to Figure 5.20 
A: Calibration curve correspondent to HAuCl4 concentration of 0.010 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.02 M. 
 In both of the cases with volume ratios (HAuCl4 : Amoxicillin) of 2 µL:7 µL and 4 µL:9 
µL, the best results were obtained with a concentration of HAuCl4 of 0.010 M. When comparing 
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these two results, preference was given to the volume ratio of 4 µL:9 µL, because it presented 
more colour intensity in the wells and a calibration curve with lower standard deviation for higher 
antibiotic concentrations. 
5.3.2 Ampicillin 
 Figure 5.22 presents the results obtained after variation of the HAuCl4 concentration for 
the volume ratio (HAuCl4:Ampicillin) of 4 µL:9 µL. As before in Figure 5.16, ampicillin contin-
ues to be the antibiotic with less colour intensity and less colour changes along the microplate 
line. As it can be seen in Figure 5.22, the case in which slight colour changes occur, is the case 
with a concentration of HAuCl4 of 0.010 M. The lowest and highest HAuCl4 concentration do not 
present visible colour changes with the increase of antibiotic concentration.  
HAuCl4 
Concentration  
(M) 
Ampicillin Concentration (mM) 
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Figure 5.22 Variation of the concentration of HAuCl4 for the volume ratio (HAuCl4:Ampi-
cillin) of 4 µL:9 µL 
Along the lines of the microplate, varies the concentration of antibiotic from 0.0100 mM to 1.0000 mM 
and along the columns varies the concentration of HAuCl4 ∙ 3H2O. The first column of each line corre-
sponds to the control well, without antibiotic.  
 The case with a concentration of HAuCl4 of 0.010 M was also the case with a better 
calibration curve, which is presented in Figure 5.23. The calibration curves of the rest of the cases 
are presented in Figure C. 1 (in the Annex), where it is possible to observe that the calibration 
curves correspondent to higher HAuCl4 concentrations also have lower R-squared, indicating 
poorest fit of the terms. The calibration curve with higher R-squared is the calibration curve cor-
respondent to HAuCl4 concentration of 0.010 M. Preference was given to this case, because it 
had better visual properties on paper and a calibration curve with higher R-squared and an expo-
nential fit, common to paper-based sensors with gold nanoparticles. 
49 
0.0 0.2 0.4 0.6 0.8 1.0
1.01
1.02
1.03
1.04
1.05
1.06
1.07
1.08
y = 1.08 - 0.07e
-2.41x
R
2
 = 0.99
 
 
R
e
d
/G
re
e
n
 R
a
ti
o
Antibiotic Concentration (mM)
0.010 M
 
Figure 5.23 Calibration curves corresponding to Figure 2.22 
Calibration curve correspondent to HAuCl4 concentration of 0.010 M 
5.3.3 Ceftazidime 
 Figures 5.24 and 5.25 present the results obtained after variation of the HAuCl4 concen-
tration for the volume ratio (HAuCl4:Ceftazidime) of 4 µL:9 µL and 3 µL:7.5 µL, respectively.  
HAuCl4 
Concentration  
(M) 
Ceftazidime Concentration (mM) 
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Figure 5.24 Variation of the concentration of HAuCl4 for the volume ratio (HAuCl4 : 
Ceftazidime) of 4 µL:9 µL 
Along the lines of the microplate, varies the concentration of antibiotic from 0.0100 mM to 1.0000 mM 
and along the columns varies the concentration of HAuCl4 ∙ 3H2O. The first column of each line corre-
sponds to the control well, without antibiotic.  
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HAuCl4 
Concentration  
(M) 
Ceftazidime Concentration (mM) 
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Figure 5.25 Variation of the concentration of HAuCl4 for the volume ratio (HAuCl4 : 
Ceftazidime) of 3 µL:7.5 µL 
Along the lines of the microplate, varies the concentration of antibiotic from 0.0100 mM to 1.0000 mM 
and along the columns varies the concentration of HAuCl4 ∙ 3H2O. The first column of each line corre-
sponds to the control well, without antibiotic.  
 In both Figures 5.24 and 5.25, it is possible to observe that as HAuCl4 concentration 
increases, the range in which there is a grey/brown colouration in the wells also increases, rising 
the LOD visible to the naked eye and decreasing the range in which the sensor works. The cases 
with a lower LOD visible to the naked eye, correspondent to HAuCl4 concentration of 0.006 M 
and 0.010 M, present a higher colour intensity and an increase of colour intensity with the increase 
of antibiotic concentration. Although the highest antibiotic concentration (1.0000 mM) has a col-
our less intense than the antibiotic concentration before (0.5000 mM), for HAuCl4 concentration 
of 0.006 M, it is still possible to distinct from the control well. 
 Considering the calibration curves, is possible to observe that all the calibration curves 
have high R-squared, indicating a good fit of the terms. The calibration curves with higher R-
squared are the calibration curves correspondent to HAuCl4 concentration of 0.006 M and 0.010 
M, which is in line with the cases with better optical properties on paper. The calibration curves 
of these two cases are presented in Figure 5.26 and 5.27 while the other calibration curves are 
presented in Figure D. 1 and D. 2 (in the Annex). 
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Figure 5.26 Calibration curves corresponding to Figure 5.24 
A: Calibration curve correspondent to HAuCl4 concentration of 0.006 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.010 M. 
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Figure 5.27 Calibration curves corresponding to Figure 5.25 
A: Calibration curve correspondent to HAuCl4 concentration of 0.006 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.010 M. 
 In both of the cases with volume ratios (HAuCl4 : Ceftazidime) of 3 µL:7.5 µL and 4 
µL:9 µL, preference was given to HAuCl4 concentration of 0.006 M, due to the lower LOD visible 
to the naked eye (0.010 M) and the better calibration curves, with higher R-squared and a curve 
that contained the highest antibiotic concentration sample. When comparing these two results, 
preference is given to the volume ratio of 4 µL:9 µL, because it presents more colour intensity in 
the wells and a calibration curve with lower standard deviations and a higher Red/Green ratio. It 
is also the calibration curve which allows a better distinction between the control well (0 mM) 
and the well with 0.0100 mM of antibiotic. 
 It can be concluded that the optimum volume ratio HAuCl4 : Antibiotic is 4 µL:9 µL for 
the three antibiotics and that the optimum HAuCl4 concentration is 0.010 M for amoxicillin and 
ampicillin, and 0.006 M for ceftazidime. These optimum results are summed up in Figure 5.28 
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and their calibration curves are presented in Figure 5.29. The LOD visible to the naked eye is 
0.0650 mM for amoxicillin, 0.1000 mM for ampicillin and 0.0100 mM for ceftazidime, which 
indicates that after dilution, the antibiotic to test must have a final concentration between these 
values and 1.0000 mM. 
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Figure 5.28 Sum up of the optimum results of synthesis of GNPs on paper substrate 
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Figure 5.29 Sum up of the calibration curves of the optimum results for synthesis of GNPs 
on paper substrate 
A: Calibration curve of the sensor for Amoxicillin; B: Calibration curve of the sensor for Ampicillin;  
C: Calibration curve of the sensor for ceftazidime. 
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 In Figure 5.29, the calibration curves for the final sensor present an exponential fit, indi-
cating that as the antibiotic concentration continues to increase, a saturation point will be reached. 
This saturation behaviour is common in these type of devices [72]. In Figures 5.29 - A and 5.29 
– B the point of saturation is not reached with the range of antibiotic concentration used in this 
thesis. In Figure 5.29 – C it is possible to observe that the Red/Green Ratio stabilizes from ap-
proximately 0.6 mM. Therefore, the range of antibiotic concentrations that this sensor can quan-
tify is up to 0.6 mM. This indicate that the diluted solution of the antibiotic to test must be less 
than 0.6 mM. 
5.4 Testing common drug replacements 
 To test if the developed system is feasible to be used for the detection of falsified antibi-
otics, the antibiotics were replaced by gelatine, sodium bicarbonate, acetylsalicylic acid, calcium 
carbonate, D-(-)-fructose and D-(+)-galactose. First these substitutes were used in the procedure 
for synthesis of GNPs in solution, then in the procedure for synthesis of GNPs on paper substrate. 
Figures 5.30, 5.31 and 5.32 present the UV-Vis spectrophotometry analysis of solutions upon 
addition of those ingredients and Figures 5.33 and 5.34 present the results of the same substitutes 
on paper substrate. These experiences were repeated three times each and similar results were 
obtained. 
 To test common drug replacements, the ingredients previously mentioned were used in 
concentrations between 0.0100 mM and 1.0000 mM, com exception gelatine and calcium car-
bonate, and compared with the results obtained in Sections 5.1 and 5.3. As mentioned in Section 
4.4, the tests for calcium carbonate used a smaller range of concentrations (between 0.1300 mM 
and 0.0100 mM) due to the low solubility of this ingredient in water. Also, the tests for gelatine 
were done only for concentrations between 0.0325 mM and 1.0000 mM. 
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Figure 5.30 UV-Vis spectrophotometry analysis of solutions upon addition of sodium bi-
carbonate and D-(+)-galactose 
A: Sodium bicarbonate; B: D-(+)-galactose. 
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Figure 5.31 UV-Vis spectrophotometry analysis of solutions upon addition of D-(-)-fruc-
tose and acetylsalicylic acid 
A: D-(-)-fructose; B: Acetylsalicylic acid 
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Figure 5.32 UV-Vis spectrophotometry analysis of solutions upon addition of gelatine and 
calcium carbonate 
A: Gelatine; B: Calcium carbonate 
 In Figures 5.30 and 5.32 there is no absorption SPR peak in the visible region of the 
electromagnetic spectrum, characteristic of GNPs, indicating that there is no reduction of HAuCl4 
by sodium bicarbonate, D-(+)-galactose, gelatine or calcium carbonate, and consequently, no for-
mation of GNPs. In Figure 5.31 an absorption SPR peak between 500 nm and 600 nm can be 
observed, indicating a formation of GNPs. In the case of D-(-)-fructose, all concentrations be-
tween 0.0100 mM and 1.0000 mM form GNPs as expected, because fructose has been used to 
form GNPs [73]. In the case of acetylsalicylic acid, there is only formation of GNPs for the highest 
concentration (1.0000 mM), due to the presence of monosodium citrate in the migraspirin tablet 
beyond acetylsalicylic acid. Such as fructose, sodium citrate is also used in the formation of GNPs 
[74]. In addition, theses graphics present more noise than the graphics correspondent to the syn-
thesis of GNPs using antibiotics. A detection based only on the synthesis of GNPs in solution 
would not be enough to distinguish legitimate antibiotics from falsified antibiotics. 
 Figures 5.33 and 5.34 present the results of the use of common drug replacements, in-
stead of the antibiotic, in the synthesis of GNPs on paper substrate protocol. 
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Figure 5.33 Results on paper substrate after addition of common drug replacements and 
using a HAuCl4 concentration of 0.010 M 
The blank space in the gelatine concentration of 0.0100 mM is because this substitute was made only for 
concentrations between 0.0325 mM and 1.0000 mM. 
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Figure 5.34 Results on paper substrate after addition of common drug replacements and 
using a HAuCl4 concentration of 0.006 M 
The blank space in the gelatine concentration of 0.0100 mM is because this substitute was made only for 
concentrations between 0.0325 mM and 1.0000 mM. 
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 When comparing the results present in Figures 5.33 and 5.34 with the results obtained 
by antibiotics on paper substrate (Figure 5.28), it is possible to observe that there are almost no 
colour changes as the drug replacement concentration increases. There is also a poor distinction 
between the control well (0 mM) and the wells with the substitute, indicating the non-formation 
of GNPs on paper substrate or the non-significant formation for colorimetric results. Although 
there is formation of GNPs in solution when fructose and acetylsalicylic acid are used, on paper 
substrate that does not occur, and it is possible to distinguish between the antibiotic and the sub-
stitute. It can be concluded that it is possible to distinguish between falsified and authentic anti-
biotics on paper substrate by the method described in this thesis. 
 Previous microplate paper wells with antibiotic (1.0000 mM of amoxicillin) and drug 
replacement (1.0000 mM of D-(+)-galactose) were analysed by SEM, to see if the colour change 
that occurred in the presence of the antibiotic represented the formation of GNPs. Figure 5.35 
presents the SEM images of microplate paper wells containing HAuCl4 and amoxicillin and Fig-
ure 5.36 presents the SEM images of microplate paper wells containing HAuCl4 and D-(+)-ga-
lactose.  
   
 
Figure 5.35 SEM images of microplate paper wells containing HAuCl4 and amoxicillin 
A: 5000x magnification; B: 20000x magnification. 
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Figure 5.36 SEM images of microplate paper wells containing HAuCl4 D-(+)-galactose 
A: 5000x magnification; B: 10000x magnification. 
 When comparing Figure 5.35 with Figure 5.36, it is possible to observe that the well 
containing antibiotic presents agglomerates, which may be indicative of the formed GNPs. These 
agglomerates are not present in the well containing the drug replacement, indicating that the re-
action between HAuCl4 and the drug replacements does not form GNPs. It also concludes that the 
procedure for synthesis of GNPs on office paper can be used to distinguish counterfeit antibiotics 
to legitimate antibiotics. 
 As the goal of this sensor is to distinguish, at naked eye, between falsified and legitimate 
β-lactam antibiotics, the best results occur at higher concentrations of antibiotic, namely from 
0.2500 mM. As common antibiotic dosages are 125 mg/5 mL, 250 mg/5 mL and 500 mg/5 mL, 
which correspond to approximately 0.046 M, 0.091 M and 0.183 M, respectively, the user must 
dilute the antibiotic to test into solutions with concentrations between 0.2500 mM and 0.6 mM 
(which corresponds to the saturation point). The colour visible to the naked eye of the well will 
indicate the presence or absence of the API of the antibiotic, and through the Red/Green ratio and 
the calibration curves (Figure 5.29) it is possible to identify if the API is present in lower con-
centrations than normal. 
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5.5 Final Device Protocol 
 To use the device developed in this thesis, the user must deposit 4 µL of HAuCl4 ∙ 3H2O 
on the control and sample zones and then deposit 9 µL of the antibiotic to test on the sample zone, 
without letting the HAuCl4 ∙ 3H2O dry. Only then, shall the user let the paper-based sensor dry at 
room temperature. If the antibiotic to test is amoxicillin or ampicillin, the user must use the 
HAuCl4 ∙ 3H2O with a concentration of 0.010 M. If the antibiotic to test is ceftazidime, the user 
must use the HAuCl4 ∙ 3H2O with a concentration of 0.006 M. The antibiotic to test must be 
diluted into concentrations between 0.2500 mM and 0.6 mM.  
If the sample well presents a brownish/greyish colour (Figure 5.37), it indicates that the 
gold salt was reduced by the antibiotic and confirms the presence of the API. The presence of a 
similar colour to the control well (Figure 5.38) indicates the absence of the antibiotic API, im-
plying a counterfeit β-lactam antibiotic. In cases were the presence of API is confirmed, it is 
necessary to obtain the Red/Green ratio, through digitalization and image analysis software or 
through a mobile image processing application and compare the value with the calibration curves 
presented in Figure 5.29. This will allow to identify if the API on the antibiotic to test is present 
in lower concentrations than normal.  
            
Figure 5.37 Paper-based sensor after addition of legitimate antibiotics 
 
 
Figure 5.38 Paper-based sensor after addition of counterfeit antibiotics  
 
 Table 5.1 shows the cost of raw materials to produce this device, based on the price of 
each material and reagent required. The expenditures electricity from the appliances were not 
taken in account. This paper-based sensor is all made of biodegradable materials and reduced 
volumes of reagents, which reduces production, storage and transportation costs. It has a total 
cost of 2.3 x 10-3 €. 
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Table 5.1 Cost of raw materials to produce the final device 
Materials Quantity Cost Sensor Cost 
Office Paper (5.5 x 2.4) cm2 1.9 x 10-3 €/m2 2.51 x 10-6 € 
Printing Wax 2 x (5.5 x 2.4) cm2 0.28 €/m2 7.39 x 10-4 € 
HAuCl4 ∙ 3H2O (0.010 M) 4 µL = 0.01006 mg 61.92 €/g 9.91 x 10-4 € 
HAuCl4 ∙ 3H2O (0.006 M) 4 µL = 0.009 mg 61.92 €/g 5.57 x 10-4 € 
Total Cost 2.3 x 10-3 € 
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6 Conclusions and future work 
 The main goal of this dissertation was to develop a inexpensive and user-friendly device, 
able to detect counterfeit -lactam antibiotics, using Lab-on-Paper technology and gold nanopar-
ticles. The use of paper as diagnostic support in this device presents several benefits such as low 
price, large supply with different formats and properties, compatibility with various chemicals, 
disposability, easy use and white background, which allows a colorimetric detection and facili-
tates a digital analysis.  
 In this thesis, two types of paper were characterized: office paper Portucel and Whatman 
No.1 chromatography paper. Several characterization techniques were used to evaluate these dif-
ferent types of paper and office paper revealed better properties than Whatman paper, for the 
development of this device. Office paper was found to have flatter cellulose fibres and a less 
porous and more uniform surface, due to the presence of calcium carbonate that fill most of the 
pores, which reduces the diffusion of gold salt by paper fibres. The presence of calcium carbonate 
was confirmed by FTIR and XRD, in which the office paper presented a lower purity of cellulose 
and a lower crystallinity index (69.17%), when compared to Whatman paper (74.37%). TG and 
DSC showed that the cellulose decomposition results in a lower mass loss for office paper 
(49.13%) than for Whatman paper (79.88%), due to the presence of calcium carbonate, and that 
the office paper does not present a significant degradation during the heating process.  
 The enzyme-free protocol developed showed an increase in the absorbance value and 
colour intensity, of the colloidal solutions, with the increase of antibiotic concentration. The re-
duction of gold salt by the antibiotic only produced GNPs for antibiotic concentrations from 
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0.0650 mM, establishing a LOD of 0.0650 mM. This protocol also presented direct proportional-
ity until 0.5000 mM of antibiotic concentration, indicating that the sensitivity is maintained during 
this range. To be within this range, the antibiotic to be tested must be diluted, as in the procedure 
of this thesis. Assays without the heat source demonstrated that the GNP synthesis also occurs at 
room temperature and maintains the same LOD and the direct proportionality between the ab-
sorbance value and the antibiotic concentration. These assays presented a better linear fit of the 
terms than the GNPs synthesized at 70º C and confirmed the possibility of the reaction, between 
the gold and the antibiotic, occurring on paper substrate at room temperature.  
 The protocol applied on paper substrate consisted of adding the antibiotic right after the 
deposition of HAuCl4 ∙ 3H2O, without letting it dry out. This allowed a greater diffusion and more 
homogeneous mixing of the reagents, improving the GNP formation. The obtained optimum ratio 
HAuCl4:Antibiotic was 4 µL:9 µL for the three antibiotics and that the optimum HAuCl4 concen-
tration was 0.010 M for amoxicillin and ampicillin, and 0.006 M for ceftazidime. The resulting 
LOD visible to the naked eye was 0.0650 mM for amoxicillin, 0.1000 mM for ampicillin and 
0.0100 mM for ceftazidime. These conditions presented an increase of colour intensity with anti-
biotic concentration, a good distinction between the control well and the wells with antibiotic, 
and calibration curves with lower standard deviations and higher R-squared.  
 Testing the previous protocols with common drug replacements, such as gelatine, sodium 
bicarbonate, acetylsalicylic acid, calcium carbonate, D-(-)-fructose and D-(+)-galactose, con-
firmed the possibility of using this device to detect counterfeit -lactam antibiotics. Although 
GNPs were synthesized in solution upon addition of D-(-)-fructose and acetylsalicylic acid, this 
did not occur when applied on paper substrate. On paper substrate, no significant colour changes 
occurred with the increase of drug replacement concentration, indicating the non-formation of 
GNPs or the non-significant formation for colorimetric results. The SEM analysis allowed the 
observation of agglomerates, probably GNPs, in the microplate well containing antibiotic and its 
absence in the microplate well containing a common drug replacement. This indicates that the 
procedure for synthesis of GNPs on office paper can be used to distinguish counterfeit antibiotics 
to legitimate antibiotics. 
 As the main goal of the developed sensor is to distinguish, at naked eye, between falsified 
and legitimate β-lactam antibiotics, the antibiotic concentration range was chosen between 0.2500 
mM and 0.6 mM. This range is below the saturation point and presented the wells with higher 
colour intensity, upon addition of the antibiotic. As common antibiotic dosages are 125 mg/5 mL, 
250 mg/5 mL and 500 mg/5 mL, which correspond to approximately 0.046 M, 0.091 M and 0.183 
M, respectively, the antibiotic to test must be diluted into concentrations between 0.2500 mM and 
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0.6 mM. In addition, these values presented Red/Green ratios distinct from each other, allowing 
the user to calculate the dosage of API and compare it with the results obtained in this thesis. The 
sensor detection is based on checking for the presence of the active pharmaceutical ingredient in 
the antibiotic, through a brownish/greyish colour in the sample well and verifying if it is within 
the correct dosage. When comparing this sensor to the devices mentioned in the State of the Art, 
this device has the advantage of allowing a quantitative analysis. 
 This device consisted of a microfluidic paper-based platform, obtained by Lab-on-Paper 
technology, with an enzyme-free detection, based on the use of gold nanoparticles, which made 
the final device low-cost and with a longer shelf life than a biosensor with enzymes. This device 
does not require the use inside a laboratory and can be useful in hospitals, clinics, pharmacies and 
non-governmental organizations, especially in less developed countries. Users can use this sensor 
when patients do not respond to medication, to determine if the cause is a counterfeit antibiotic, 
or as a quality assurance during the purchasing process. To bring this device to general use, im-
provements and optimizations must be made.  
 As future work, a trial with more samples must be done, to calculate the false positives 
and false negatives and consequently, obtain the sensor error. Furthermore, another control well 
can be added on the final sensor, in which only antibiotic is placed, and other excipients can be 
tested to see if they reduce the gold salt and may interfere with the results. Also, the evaluation 
of the size and shape of the GNPs present in the colloidal solutions, through dynamic light scat-
tering and transmission electron microscopy, would be interesting to see if the size and shape vary 
with the concentration of antibiotic and with the type of antibiotic. Another suggestion is the 
development of a smartphone application, that automatically analyses the sample well, obtains 
the API dosage and indicates if the antibiotic is counterfeit or legitimate. 
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I. Annex 
A.  Calculation of the molar concentrations of gelatine 
M: Molar mass (g/mol) 
C: Molar concentration (mol/L) 
Cm: Mass concentration (g/L) 
n: number of moles (mol) 
m: mass (g) 
v: volume (L) 
 
Table A. 1 Correspondent mass concentration of ceftazidime 
Molar concentration of  
ceftazidime (mM) 
Correspondent mass concentration of 
ceftazidime (mg/mL) 
0.0100 5.466 x 10-3 
0.0325 0.0101 
0.0650 0.0355 
0.1000 0.0547 
0.1300 0.0711 
0.2500 0.1301 
0.3000 0.1640 
0.5000 0.2733 
1.0000 0.5000 
 
𝑀𝑐𝑒𝑓𝑡𝑎𝑧𝑖𝑑𝑖𝑚𝑒 = 546.58 𝑔/𝑚𝑜𝑙 
𝐶𝑚 =  
𝑚
𝑣
=
𝑛 × 𝑀
𝑣
=
𝐶 × 𝑣 × 𝑀
𝑣
= 𝐶 × 𝑀 
 
𝑛 =
𝑚
𝑀
 
 
𝐶 =
𝑛
𝑣
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B. Calibration curves corresponding to the paper microplates with amoxi-
cillin 
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Figure B. 1 Calibration curves corresponding to Figure 5.18 
A: Calibration curve correspondent to HAuCl4 concentration of 0.006 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.040 M; C: Calibration curve correspondent to HAuCl4 concentra-
tion of 0.100 M 
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Figure B. 2 Calibration curves corresponding to Figure 5.20 
A: Calibration curve correspondent to HAuCl4 concentration of 0.006 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.040 M; C: Calibration curve correspondent to HAuCl4 concentra-
tion of 0.100 M 
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C. Calibration curves corresponding to the paper microplates with ampicil-
lin 
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Figure C. 1 Calibration curves corresponding to Figure 2.22 
A: Calibration curve correspondent to HAuCl4 concentration of 0.006 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.020 M; C: Calibration curve correspondent to HAuCl4 concentra-
tion of 0.040 M; D: Calibration curve correspondent to HAuCl4 concentration of 0.100 M 
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D. Calibration curves corresponding to the paper microplates with 
ceftazidime 
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Figure D. 1 Calibration curves corresponding to Figure 5.24 
A: Calibration curve correspondent to HAuCl4 concentration of 0.020 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.040 M; C: Calibration curve correspondent to HAuCl4 concentra-
tion of 0.100 M 
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Figure D. 2 Calibration curves corresponding to Figure 5.25 
A: Calibration curve correspondent to HAuCl4 concentration of 0.020 M; B: Calibration curve corre-
spondent to HAuCl4 concentration of 0.040 M; C: Calibration curve correspondent to HAuCl4 concentra-
tion of 0.100 M 
 
